"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL12948";"SEMUSTINE";"3.0";"247.73";"0";"2.50";"SEMUSTINE";"CC1CCC(NC(=O)N(CCCl)N=O)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL689";"MANNITOL";"4.0";"182.17";"1";"-3.59";"MANNITOL";"OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL440824";"";"None";"3256.82";"None";"None";"22";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)NCCCCCCCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"6.6";"nM";"8.18";"";"";"UO_0000065";"2.51";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL2440199";"";"None";"810.96";"2";"-1.62";"22";"CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL64";"ISONIAZID";"4.0";"137.14";"0";"-0.31";"INH";"NNC(=O)c1ccncc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909069";"";"None";"None";"None";"None";"MC 288769";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL277100";"TEMAFLOXACIN";"4.0";"417.39";"0";"2.90";"TEMAFLOXACIN";"CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1384";"KANAMYCIN";"4.0";"484.50";"2";"-7.29";"KANAMYCIN";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL105";"MITOMYCIN";"4.0";"334.33";"0";"-1.65";"MITOMYCIN C";"CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1191";"SULFAMETHIZOLE";"4.0";"270.34";"0";"1.23";"SULFAMETHIZOLE";"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1679";"LEUCOVORIN";"4.0";"473.45";"1";"-0.73";"LEUCOVORIN";"Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440197";"";"None";"1662.93";"None";"None";"19";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1220";"TINIDAZOLE";"4.0";"247.28";"0";"0.53";"TINIDAZOLE";"CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1243";"SULFABENZAMIDE";"4.0";"276.32";"0";"1.39";"SULFABENZAMIDE";"Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL508112";"BENZOTHIAZYL DISULFIDE";"None";"332.50";"1";"5.71";"BENZOTHIAZYL DISULFIDE";"c1ccc2sc(SSc3nc4ccccc4s3)nc2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL12856";"INAMRINONE";"4.0";"187.20";"0";"1.02";"AMRINONE";"Nc1cc(-c2ccncc2)c[nH]c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1046";"AMINOCAPROIC ACID";"4.0";"131.18";"0";"0.59";"AMINOCAPROIC ACID";"NCCCCCC(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL282575";"ESTRADIOL BENZOATE";"4.0";"376.50";"1";"5.12";"BETA-ESTRADIOL 3-BENZOATE";"C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL397529";"";"None";"1743.06";"None";"None";"18";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C1CCCC(N)C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"3.99";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL506";"PRIMAQUINE";"4.0";"259.35";"0";"2.78";"PRIMAQUINE";"COc1cc(NC(C)CCCN)c2ncccc2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1373";"MODAFINIL";"4.0";"273.36";"0";"2.01";"MODAFINIL";"NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4289021";"";"None";"4036.49";"None";"None";"19";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"1.88";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4282168";"";"None";"1737.99";"None";"None";"34";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"3.162";"nM";"8.50";"";"";"UO_0000065";"4.89";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4282216";"";"None";"4034.47";"None";"None";"23";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CN(C(=N)N)C[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"7900.0";"nM";"5.10";"";"";"UO_0000065";"1.26";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL311350";"PIROMIDIC ACID";"2.0";"288.31";"0";"1.11";"PIROMIDIC ACID";"CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL428017";"";"None";"1787.11";"None";"None";"PYY(24-36)-L31";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"4.64";"None";"None";"None";"0";"CHEMBL897470";"Displacement of [125I]PYY from human NPY2 receptor in KAN-TS cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148865";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL444633";"RIFABUTIN";"4.0";"847.02";"2";"4.62";"RIFABUTIN";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1908847";"SPARTEINE";"4.0";"234.39";"0";"2.35";"SPARTEINE";"C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@@H]34)[C@H]2C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL119385";"NEFLAMAPIMOD";"2.0";"436.27";"1";"5.49";"VX-745";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3104112";"";"None";"4059.65";"None";"None";"196";"CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)c1cccnc1SCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"9.1";"nM";"8.04";"";"";"UO_0000065";"1.98";"None";"None";"None";"0";"CHEMBL3106329";"Binding affinity to NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL420";"GUANABENZ";"4.0";"231.09";"0";"1.81";"GUANABENZ";"N=C(N)N/N=C/c1c(Cl)cccc1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL85728";"4,4'-METHYLENEDIANILINE";"None";"198.27";"0";"2.44";"4,4'-METHYLENEDIANILINE";"Nc1ccc(Cc2ccc(N)cc2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL410007";"";"None";"3385.80";"None";"None";"14";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCCNC(=O)CC[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N[C@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N2CCC[C@@H]2C(=O)N[C@H](C)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)N[C@H](C)C(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"2.78";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1909062";"LEAD (II) ACETATE";"None";"325.29";"None";"None";"LEAD (II) ACETATE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909065";"MADURAMICIN";"2.0";"917.14";"2";"4.32";"LYSERGOL";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL488025";"EXISULIND";"3.0";"372.42";"0";"4.03";"SULINDAC SULFONE";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL866";"MYCOPHENOLIC ACID";"4.0";"320.34";"0";"2.73";"MYCOPHENOLIC ACID";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL19236";"MOXONIDINE";"4.0";"241.68";"0";"0.82";"MOXONIDINE";"COc1nc(C)nc(Cl)c1NC1=NCCN1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL6";"INDOMETHACIN";"4.0";"357.79";"0";"3.93";"INDOMETHACIN";"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL841";"LOPERAMIDE";"4.0";"477.05";"1";"5.09";"loperamide";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL476";"DACARBAZINE";"4.0";"182.19";"0";"0.07";"DACARBAZINE";"CN(C)/N=N/c1[nH]cnc1C(N)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL130";"CHLORAMPHENICOL";"4.0";"323.13";"0";"0.91";"CHLORAMPHENICOL";"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1626";"CLEMASTINE";"4.0";"343.90";"1";"5.10";"CLEMASTINE";"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2371909";"";"None";"1696.01";"None";"None";"3";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"3.80";"None";"None";"None";"0";"CHEMBL870718";"Displacement of [125I]NPY from human NPY2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146122";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1451";"TRIAMCINOLONE";"4.0";"394.44";"0";"0.62";"TRIAMCINOLONE";"C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"1.97";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL269267";"";"None";"1931.24";"None";"None";"3";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"4.17";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL123413";"";"None";"452.04";"1";"5.86";"12";"Cn1c(COc2ccc(Cl)cc2)c(CN2CCC(N3CCCCC3)CC2)c2ccccc21";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"2.09";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL414051";"";"None";"2276.64";"None";"None";"5";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"3.97";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL413871";"";"None";"2299.73";"None";"None";"6";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"3.17";"None";"None";"None";"0";"CHEMBL870718";"Displacement of [125I]NPY from human NPY2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146122";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"152.0";"nM";"6.82";"";"";"UO_0000065";"1.60";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL411765";"";"None";"1767.03";"None";"None";"17";"COc1cc(C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)[C@@H](C)O)C(C)C)ccc1N";"Ki";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"4.70";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL123410";"";"None";"403.35";"1";"6.05";"10";"Cn1c(COc2ccc(Cl)cc2Cl)c(CN2CCCCC2)c2ccccc21";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"FLUNARIZINE";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1140";"NIACINAMIDE";"4.0";"122.13";"0";"0.18";"NIACINAMIDE";"NC(=O)c1cccnc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200656";"NATAMYCIN";"4.0";"665.73";"3";"0.12";"PIMARICIN";"C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL305660";"EBASTINE";"4.0";"469.67";"1";"7.22";"EBASTINE";"CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL94";"PHYSOSTIGMINE";"4.0";"275.35";"0";"1.77";"PHYSOSTIGMINE";"CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL80";"NALOXONE";"4.0";"327.38";"0";"1.30";"NALOXONE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL914";"FEXOFENADINE";"4.0";"501.67";"2";"5.51";"FEXOFENADINE";"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"2.06";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL3349341";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"1.99";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1612004";"";"None";"123.15";"0";"1.28";"O-ANISIDINE";"COc1ccccc1N";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL14060";"PHENOL";"4.0";"94.11";"0";"1.39";"PHENOL";"Oc1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL91";"MICONAZOLE";"4.0";"416.13";"1";"6.45";"MICONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL427966";"";"None";"3318.80";"None";"None";"15";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCCNC(=O)CC[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N2CCC[C@@H]2C(=O)N[C@H](C)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"2.54";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"2.13";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL563037";"";"None";"495.55";"1";"5.58";"27";"CC(C)(C(=O)Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(C(F)(F)F)c1)c1ccccc1";"Ki";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL4645462";"";"None";"861.02";"3";"-4.18";"19";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4634913";"";"None";"1097.25";"None";"None";"25";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4643341";"";"None";"1047.24";"None";"None";"27";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4540843";"PANCREATIC POLYPEPTIDE";"2.0";"4181.78";"None";"None";"hPP";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4640794";"";"None";"968.13";"3";"-2.68";"15";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4646733";"";"None";"951.15";"3";"-2.57";"18";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4641329";"";"None";"1154.35";"None";"None";"28";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4646230";"";"None";"678.80";"2";"-1.55";"30";"N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4633593";"";"None";"967.15";"3";"-2.87";"1; UR-KK236";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL991";"STAVUDINE";"4.0";"224.22";"0";"-0.71";"STAVUDINE";"Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1308";"FOMEPIZOLE";"4.0";"82.11";"0";"0.72";"4-METHYLPYRAZOLE";"Cc1cn[nH]c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL980";"GUAIFENESIN";"4.0";"198.22";"0";"0.43";"GUAIFENESIN";"COc1ccccc1OCC(O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909070";"NAFENOPIN";"2.0";"310.39";"0";"4.40";"NAFENOPIN";"CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL898";"DIFLUNISAL";"4.0";"250.20";"0";"3.04";"DIFLUNISAL";"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL685";"MEBENDAZOLE";"4.0";"295.30";"0";"2.97";"MEBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2370632";"";"None";"2199.51";"None";"None";"9";"CC[C@H](C)[C@H](NC(=O)[C@@H]1CNC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CC(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"4.01";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1208572";"SALINOMYCIN";"2.0";"751.01";"2";"6.19";"SALINOMYCIN";"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL415324";"TRANILAST";"3.0";"327.34";"0";"3.05";"TRANILAST";"COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1908355";"TENIDAP";"2.0";"320.76";"0";"3.25";"TENIDAP";"NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL103";"PROGESTERONE";"4.0";"314.47";"0";"4.72";"PROGESTERONE";"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1089";"PHENELZINE";"4.0";"136.20";"0";"0.69";"PHENELZINE";"NNCCc1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL452861";"(-)-PROPANOLOL ";"2.0";"259.35";"0";"2.58";"S-(-)-PROPRANOLOL";"CC(C)NC[C@H](O)COc1cccc2ccccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL15770";"SULINDAC";"4.0";"356.42";"0";"4.37";"SULINDAC";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL128";"SUMATRIPTAN";"4.0";"295.41";"0";"1.32";"SUMATRIPTAN";"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL561";"LOMEFLOXACIN";"4.0";"351.35";"0";"1.80";"LOMEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL503";"LOVASTATIN";"4.0";"404.55";"0";"4.20";"LOVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1539";"SULFADOXINE";"4.0";"310.34";"0";"0.88";"SULFADOXINE";"COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL817";"TOLAZAMIDE";"4.0";"311.41";"0";"1.77";"TOLAZAMIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL427526";"(R)-IBUPROPHEN";"1.0";"206.28";"0";"3.07";"R(-)-IBUPROFEN";"CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL439904";"";"None";"4049.53";"None";"None";"1";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"2.32";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL227456";"";"None";"1737.01";"None";"None";"11";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"4.83";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL406";"INDAPAMIDE";"4.0";"365.84";"0";"2.08";"INDAPAMIDE";"CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1256017";"ARCAINE SULFATE";"None";"270.31";"1";"-1.27";"ARCAINE SULFATE";"N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3084803";"ASTROMICIN";"-1.0";"405.50";"1";"-3.59";"ASTROMICIN";"CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL113";"CAFFEINE";"4.0";"194.19";"0";"-1.03";"CAFFEINE";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4290048";"";"None";"4007.49";"None";"None";"33";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"1.62";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4277590";"";"None";"4052.50";"None";"None";"39";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"2.29";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL13341";"NIMETAZEPAM";"2.0";"295.30";"0";"2.41";"NIMETAZEPAM";"CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4549208";"";"None";"1762.10";"None";"None";"(2S,7S)-10";"CCC(=O)N[C@H](CCCC[C@@H](N)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"3.48";"None";"None";"None";"0";"CHEMBL4478050";"Displacement of [3H]propionyl-pNPY from human NPY Y2 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477203";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3787766";"";"None";"1676.01";"None";"None";"16";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"3.44";"None";"None";"None";"0";"CHEMBL4478050";"Displacement of [3H]propionyl-pNPY from human NPY Y2 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477203";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL411766";"";"None";"1763.05";"None";"None";"19";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C1Cc2ccccc2N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"4.39";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL266814";"";"None";"1751.04";"None";"None";"16";"Cc1cc(C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)[C@@H](C)O)C(C)C)ccc1N";"Ki";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"4.70";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL437421";"";"None";"2301.65";"None";"None";"12";"CC[C@H](C)[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](C)NC(=O)[C@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N)Cc2ccc(O)cc2)CCCCNC(=O)CC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC1=O";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"4.04";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1255834";"BW-723C86";"None";"286.40";"0";"3.70";"BW-723C86";"CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1006";"AMIFOSTINE";"4.0";"214.23";"0";"-0.25";"AMIFOSTINE";"NCCCNCCSP(=O)(O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL631";"PROPAFENONE";"4.0";"341.45";"0";"3.24";"PROPAFENONE";"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1518";"PROPYLTHIOURACIL";"4.0";"170.24";"0";"1.38";"PROPYLTHIOURACIL";"CCCc1cc(=O)[nH]c(=S)[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909073";"PIPERILATE ETHOBROMIDE";"None";"448.40";"0";"3.49";"PIPERILATE ETHOBROMIDE";"CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL702";"PIPERACILLIN";"4.0";"517.56";"1";"-0.24";"PIPERACILLIN";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1237174";"HYDRAZINE";"0.5";"32.05";"0";"-1.18";"HYDRAZINE";"NN";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL411117";"";"None";"2382.81";"None";"None";"7";"CC[C@H](C)[C@H](N)C(=O)N[C@H]1CCC(=O)NC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)OC)NC(=O)[C@@H]2CCCN2C(=O)[C@H](NC(=O)[C@@H](N)[C@@H](C)CC)CCC(=O)NC[C@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)OC)NC(=O)[C@@H]2CCCN2C1=O";"Ki";"'='";"1036.0";"nM";"5.99";"";"";"UO_0000065";"2.51";"None";"None";"None";"0";"CHEMBL752930";"Affinity for cloned Y2 receptor using [125I]PYY as radioligand";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134468";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL1618305";"NALOXONAZINE";"None";"650.78";"1";"3.28";"NALOXONAZINE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL119443";"ERGONOVINE";"4.0";"325.41";"0";"1.53";"ERGONOVINE";"C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL63560";"(R)-BICALUTAMIDE";"None";"430.38";"0";"2.88";"(R)-BICALUTAMIDE";"C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL573";"NIACIN";"4.0";"123.11";"0";"0.78";"NIACIN";"O=C(O)c1cccnc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL480";"LANSOPRAZOLE";"4.0";"369.37";"0";"3.52";"LANSOPRAZOLE";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2";"PRAZOSIN";"4.0";"383.41";"0";"1.78";"Prazosin";"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL426123";"";"None";"258.23";"0";"0.09";"(-)-THALIDOMIDE";"O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3039597";"GENTAMICIN";"4.0";"1390.73";"None";"None";"GENTAMICIN";"CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H](N)C[C@@H]2N)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL502896";"CETRAXATE HYDROCHLORIDE";"-1.0";"341.83";"0";"2.37";"CETRAXATE";"Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL205596";"CHOLIC ACID";"4.0";"408.58";"0";"3.45";"7";"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL806";"FLUTAMIDE";"4.0";"276.21";"0";"3.21";"FLUTAMIDE";"CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL177";"AMIKACIN";"4.0";"585.61";"3";"-8.42";"AMIKACIN";"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL510139";"CITRININ";"None";"250.25";"0";"1.72";"CITRININ";"CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL891";"CLOXACILLIN";"4.0";"435.89";"0";"2.55";"CLOXACILLIN";"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909056";"COBALT(II) ACETYLACETONATE";"None";"257.15";"None";"None";"COBALT(II) ACETYLACETONATE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200624";"ETHYNODIOL DIACETATE";"4.0";"384.52";"0";"4.43";"ETHYNODIOL DIACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1487";"ATORVASTATIN";"4.0";"558.65";"2";"6.31";"ATORVASTATIN";"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1405";"ESTRONE";"4.0";"270.37";"0";"3.82";"ESTRONE";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL456";"ETHACRYNIC ACID";"4.0";"303.14";"0";"3.61";"ETHACRYNIC ACID";"C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL53463";"DOXORUBICIN";"4.0";"543.53";"3";"0.00";"DOX";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL485259";"EUCALYPTOL";"3.0";"154.25";"0";"2.74";"EUCALYPTOL";"CC12CCC(CC1)C(C)(C)O2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4281120";"";"None";"4022.46";"None";"None";"20";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"1.64";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1288138";"";"None";"413.99";"1";"5.22";"20";"CC(C)NC1CCN(c2ccc(NC(=O)C(C)(C)c3ccccc3)cc2Cl)CC1";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1288170";"";"None";"426.00";"1";"5.22";"23";"CC(C)(C(=O)Nc1ccc(N2CCC(NCC3CC3)CC2)c(Cl)c1)c1ccccc1";"Ki";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1288284";"";"None";"479.97";"1";"5.86";"30";"CC(C)(C(=O)Nc1ccc(N2CCC3(CCNC3)CC2)c(Cl)c1)c1cccc(C(F)(F)F)c1";"Ki";"'='";"15.85";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL438548";"";"None";"1760.14";"None";"None";"1";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CSSC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL870718";"Displacement of [125I]NPY from human NPY2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146122";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1628227";"DOXEPIN";"4.0";"279.38";"0";"3.96";"DOXEPIN";"CN(C)CCC=C1c2ccccc2COc2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL227934";"STRYCHNINE";"-1.0";"334.42";"0";"2.09";"STRYCHNINE";"O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL121";"ROSIGLITAZONE";"4.0";"357.44";"0";"2.49";"ROSIGLITAZONE";"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL18701";"RO-201724";"None";"278.35";"0";"2.10";"Ro-201724";"CCCCOc1cc(CC2CNC(=O)N2)ccc1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"AMIODARONE";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL263848";"";"None";"3340.85";"None";"None";"16";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N)Cc2ccc(O)cc2)C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"2.65";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL75880";"PERHEXILINE";"4.0";"277.50";"1";"5.30";"PERHEXILINE";"C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL40";"PHENOBARBITAL";"4.0";"232.24";"0";"0.70";"PHENOBARBITAL";"CCC1(c2ccccc2)C(=O)NC(=O)NC1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200391";"TROMETHAMINE";"4.0";"121.14";"0";"-2.34";"TROMETHAMINE";"NC(CO)(CO)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL650";"METHYLPREDNISOLONE";"4.0";"374.48";"0";"1.80";"METHYLPREDNISOLONE";"C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL54440";"MEVASTATIN";"2.0";"390.52";"0";"3.95";"MEVASTATIN";"CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349038";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"2.04";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL265391";"";"None";"1192.48";"None";"None";"3";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)CC";"Ki";"'='";"1650.0";"nM";"5.78";"";"";"UO_0000065";"4.85";"None";"None";"None";"0";"CHEMBL752928";"Affinity for cloned Y2 receptor using [125I]PYY as radioligand";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134468";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"2.10";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL521606";"NADOLOL";"4.0";"309.41";"0";"0.63";"NADOLOL";"CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL115769";"";"None";"334.35";"0";"3.97";"RWJ-68354";"COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1070";"NABUMETONE";"4.0";"228.29";"0";"3.37";"NABUMETONE";"COc1ccc2cc(CCC(C)=O)ccc2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL717";"MEDROXYPROGESTERONE ACETATE";"4.0";"386.53";"0";"4.66";"MEDROXYPROGESTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1009";"LEVODOPA";"4.0";"197.19";"0";"0.05";"LEVODOPA";"N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1598608";"AZASETRON";"2.0";"349.82";"0";"1.52";"AZASETRON";"CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1105";"6-METHOXY-2-NAPHTHYLACETIC ACID";"-1.0";"216.24";"0";"2.48";"6-METHOXY-2-NAPHTHYLACETIC ACID";"COc1ccc2cc(CC(=O)O)ccc2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL660";"AMANTADINE";"4.0";"151.25";"0";"1.91";"AMANTADINE";"NC12CC3CC(CC(C3)C1)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL20883";"TEGAFUR";"4.0";"200.17";"0";"-0.02";"TEGAFUR";"O=c1[nH]c(=O)n(C2CCCO2)cc1F";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL428880";"CROMOLYN";"4.0";"468.37";"0";"2.11";"CROMOLYN";"O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1385840";"ERGOCORNINE";"None";"561.68";"1";"2.04";"ERGOCORNINE";"CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL506247";"TANNIC ACID";"4.0";"1701.21";"None";"None";"TANNIC ACID";"O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL70586";"SPIRADOLINE";"None";"425.40";"0";"4.56";"SPIRADOLINE";"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201151";"MESTRANOL";"4.0";"310.44";"0";"3.92";"MESTRANOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL526";"PROPOFOL";"4.0";"178.27";"0";"3.64";"PROPOFOL";"CC(C)c1cccc(C(C)C)c1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21731";"MAPROTILINE";"4.0";"277.41";"0";"4.21";"MAPROTILINE";"CNCCCC12CCC(c3ccccc31)c1ccccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL900";"ORPHENADRINE";"4.0";"269.39";"0";"3.66";"ORPHENADRINE";"Cc1ccccc1C(OCCN(C)C)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1321";"PROCARBAZINE";"4.0";"221.30";"0";"1.05";"PROCARBAZINE";"CNNCc1ccc(C(=O)NC(C)C)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1162";"NORETHINDRONE";"4.0";"298.43";"0";"3.49";"NORETHINDRONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL584";"NELFINAVIR";"4.0";"567.80";"1";"4.75";"NELFINAVIR";"Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL975";"MESNA";"4.0";"164.18";"0";"-0.20";"MESNA";"O=S(=O)([O-])CCS.[Na+]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL64391";"ITRACONAZOLE";"4.0";"705.65";"3";"5.58";"ITRACONAZOLE";"CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL714";"ALBUTEROL";"4.0";"239.31";"0";"1.31";"salbutamol";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL438";"SULFAMERAZINE";"4.0";"264.31";"0";"1.17";"SULFAMERAZINE";"Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL30327";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"None";"321.97";"1";"6.20";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1501";"FLUOCINONIDE";"4.0";"494.53";"0";"2.94";"FLUOCINONIDE";"CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL628";"PENTOXIFYLLINE";"4.0";"278.31";"0";"0.19";"PENTOXIFYLLINE";"CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3183075";"NIZATIDINE";"4.0";"331.47";"0";"1.32";"NIZATIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1103";"FURAZOLIDONE";"4.0";"225.16";"0";"0.97";"FURAZOLIDONE";"O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL712";"ANISINDIONE";"4.0";"252.27";"0";"2.86";"ANISINDIONE";"COc1ccc(C2C(=O)c3ccccc3C2=O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL41543";"";"None";"238.29";"0";"3.00";"10,11-DIHYDRO-CARBAMAZEPINE";"NC(=O)N1c2ccccc2CCc2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL264374";"BEZAFIBRATE";"4.0";"361.83";"0";"3.55";"BEZAFIBRATE";"CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL106";"FLUCONAZOLE";"4.0";"306.28";"0";"0.74";"fluconazole";"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL9419";"METACETAMOL";"2.0";"151.16";"0";"1.35";"3-ACETAMIDOPHENOL";"CC(=O)Nc1cccc(O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL131";"PREDNISOLONE";"4.0";"360.45";"0";"1.56";"PREDNISOLONE";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1262";"OXICONAZOLE";"4.0";"429.13";"1";"6.12";"OXICONAZOLE";"Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL585";"TRIAMTERENE";"4.0";"253.27";"0";"0.83";"TRIAMTERENE";"Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL265849";"";"None";"2983.39";"None";"None";"2";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"3.05";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL8";"CIPROFLOXACIN";"4.0";"331.35";"0";"1.58";"CIPROFLOXACIN";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL95764";"GLYPHOSATE";"None";"169.07";"0";"-1.20";"GLYPHOSATE";"O=C(O)CNCP(=O)(O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL294199";"CAPSAICIN";"4.0";"305.42";"0";"3.79";"CAPSAICIN";"COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2221249";"COLISTIN";"4.0";"2296.97";"None";"None";"COLISTIN";"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL438914";"";"None";"1221.47";"None";"None";"2";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OC)[C@@H](C)CC";"Ki";"'='";"1420.0";"nM";"5.85";"";"";"UO_0000065";"4.79";"None";"None";"None";"0";"CHEMBL752928";"Affinity for cloned Y2 receptor using [125I]PYY as radioligand";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134468";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL515914";"AZARIBINE";"4.0";"371.30";"1";"-1.74";"AZARIBINE";"CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL960";"LEFLUNOMIDE";"4.0";"270.21";"0";"3.25";"LEFLUNOMIDE";"Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1095699";"AZASERINE";"2.0";"173.13";"0";"-1.76";"AZASERINE";"[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL499815";"ATRACTYLOSIDE";"None";"803.00";"2";"1.67";"ATRACTYLOSIDE";"C=C1[C@@H]2CCC3[C@@](CC[C@@H]4[C@H](C(=O)O)C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@]34C)(C2)[C@@H]1O.[K+].[K+]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL437002";"";"None";"297.37";"0";"3.92";"1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1586";"BECLOMETHASONE";"2.0";"408.92";"0";"2.17";"BECLOMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL253376";"BROMHEXINE";"4.0";"376.14";"0";"4.56";"BROMHEXINE";"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1349";"VALACYCLOVIR";"4.0";"324.34";"0";"-0.80";"VALACYCLOVIR";"CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909076";"";"None";"270.38";"0";"1.21";"S-(N-BENZYLTHIOCARBAMOYL)-L-CYSTEINE";"N[C@H](CSC(=S)NCc1ccccc1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909050";"";"None";"293.41";"0";"4.09";"1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL25719";"GERANIOL";"None";"154.25";"0";"2.67";"GERANIOL";"CC(C)=CCC/C(C)=C/CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1214185";"ROXITHROMYCIN";"4.0";"837.06";"2";"2.21";"ROXITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL157101";"KETOCONAZOLE";"4.0";"531.44";"1";"4.21";"Ket";"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL429";"LABETALOL";"4.0";"328.41";"0";"2.14";"LABETALOL";"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL24944";"TRIBROMSALAN";"4.0";"449.92";"0";"4.93";"TRIBROMSALAN";"O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL79";"LIDOCAINE";"4.0";"234.34";"0";"2.58";"LIDOCAINE";"CCN(CC)CC(=O)Nc1c(C)cccc1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL46";"ONDANSETRON";"4.0";"293.37";"0";"3.13";"ONDANSETRON";"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1512";"FLUNISOLIDE";"4.0";"434.50";"0";"2.27";"FLUNISOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201012";"FLURANDRENOLIDE";"4.0";"436.52";"0";"2.50";"FLURANDRENOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL175";"DEXIBUPROFEN";"4.0";"206.28";"0";"3.07";"DEXIBUPROFEN";"CC(C)Cc1ccc([C@H](C)C(=O)O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL282468";"CHOLINE CHLORIDE";"4.0";"139.63";"None";"None";"CHOLINE CHLORIDE";"C[N+](C)(C)CCO.[Cl-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL515";"CHLORAMBUCIL";"4.0";"304.22";"0";"3.38";"SID69624";"O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL964";"DISULFIRAM";"4.0";"296.55";"0";"3.62";"DISULFIRAM";"CCN(CC)C(=S)SSC(=S)N(CC)CC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL6466";"COUMARIN";"4.0";"146.14";"0";"1.79";"COUMARIN";"O=c1ccc2ccccc2o1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1123";"DICYCLOMINE";"4.0";"309.49";"0";"4.40";"DICYCLOMINE";"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1490";"TRIHEXYPHENIDYL";"4.0";"301.47";"0";"4.33";"TRIHEXYPHENIDYL";"OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL167911";"DICHLORVOS";"2.0";"220.98";"0";"2.68";"DICHLORVOS";"COP(=O)(OC)OC=C(Cl)Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL127282";"";"None";"4239.69";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"2.02";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL163";"RITONAVIR";"4.0";"720.96";"2";"5.91";"RITONAVIR";"CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1287985";"";"None";"403.93";"0";"4.79";"5, amine";"CC(C)(C)C(=O)Nc1ccc(N2CCN(Cc3cccc(F)c3)CC2)c(Cl)c1";"Ki";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1287870";"";"None";"417.91";"0";"4.43";"4, amide";"CC(C)(C)C(=O)Nc1ccc(N2CCN(C(=O)c3ccccc3F)CC2)c(Cl)c1";"Ki";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL409634";"";"None";"3256.82";"None";"None";"20";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H]1CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)NCCCCCCCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"2.63";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL269732";"TACROLIMUS ANHYDROUS";"4.0";"804.03";"2";"4.64";"TACROLIMUS";"C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL458019";"PARAQUAT DICHLORIDE";"None";"257.16";"0";"1.00";"PARAQUAT DICHLORIDE";"C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1321154";"ROXARSONE";"None";"263.04";"None";"None";"ROXARSONE";"O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1400945";"PREGNENOLONE CARBONITRILE ";"None";"341.50";"0";"4.26";"PREGNENOLONE-16ALPHA-CARBONITRILE";"CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"TERFENADINE";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL411793";"";"None";"1698.96";"None";"None";"0";"CC[C@@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)CCCCNC(=O)CC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC1=O";"Ki";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"4.19";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL52440";"DEXTROMETHORPHAN";"4.0";"271.40";"0";"3.38";"DEXTROMETHORPHAN";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL44";"GENISTEIN";"2.0";"270.24";"0";"2.58";"SID26665855";"O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL799";"CILOSTAZOL";"4.0";"369.47";"0";"3.46";"CILOSTAZOL";"O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL604165";"";"None";"3113.38";"None";"None";"NPY";"CSCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"2.66";"None";"None";"None";"0";"CHEMBL1066381";"Displacement of [125I]PYY from human neuropeptide Y2 receptor expressed in human SK-N-BE2 cells after 40 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL878";"METOLAZONE";"4.0";"365.84";"0";"2.71";"METOLAZONE";"Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL932";"DIPYRIDAMOLE";"4.0";"504.64";"2";"-0.02";"DIPYRIDAMOLE";"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL122841";"";"None";"466.07";"1";"5.90";"13";"Cn1c(COc2ccc(Cl)cc2)c(CCN2CCC(N3CCCCC3)CC2)c2ccccc21";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL1466";"DICUMAROL";"4.0";"336.30";"0";"2.90";"DICUMAROL";"O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"IMATINIB";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1209347";"";"None";"321.33";"0";"4.97";"1";"FC(F)(F)c1ccc(Nc2nc(-c3ccccn3)cs2)cc1";"Ki";"'>'";"31622.78";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1212052";"Antagonist activity at human NPY Y2 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208767";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3307715";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"2.19";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL26";"SULPIRIDE";"4.0";"341.43";"0";"0.56";"SULPIRIDE";"CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1288077";"";"None";"454.06";"1";"6.02";"16";"Cc1cccc(C(C)(C)C(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)c(Cl)c2)c1";"Ki";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1288200";"";"None";"494.00";"1";"6.24";"25";"CC(C)(C(=O)Nc1ccc(N2CCC(NCC3CC3)CC2)c(Cl)c1)c1cccc(C(F)(F)F)c1";"Ki";"'='";"19.95";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1431";"METFORMIN";"4.0";"129.17";"0";"-1.03";"METFORMIN";"CN(C)C(=N)NC(=N)N";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL85";"RISPERIDONE";"4.0";"410.49";"0";"3.59";"RISPERIDONE";"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL936";"DIPHENIDOL";"4.0";"309.45";"0";"4.19";"DIPHENIDOL";"OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2367892";"TEICOPLANIN";"None";"1767.46";"None";"None";"TEICOPLANIN";"CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1480987";"CYCLANDELATE";"4.0";"276.38";"0";"3.48";"CYCLANDELATE";"CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL490";"PAROXETINE";"4.0";"329.37";"0";"3.33";"PAROXETINE";"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL895";"NALBUPHINE";"4.0";"357.45";"0";"1.71";"NALBUPHINE";"Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1261";"CITRIC ACID";"4.0";"192.12";"0";"-1.25";"CITRIC ACID";"O=C(O)CC(O)(CC(=O)O)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL591971";"";"None";"1207.45";"None";"None";"BVD-15";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)CC";"Ki";"'='";"11.3";"nM";"7.95";"";"";"UO_0000065";"6.58";"None";"None";"None";"0";"CHEMBL1066381";"Displacement of [125I]PYY from human neuropeptide Y2 receptor expressed in human SK-N-BE2 cells after 40 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1201216";"DAPIPRAZOLE";"4.0";"325.46";"0";"2.29";"DAPIPRAZOLE";"Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL460499";"CARMOFUR";"2.0";"257.26";"0";"0.81";"CARMOFUR";"CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"2.08";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1909072";"PIPAMAZINE";"4.0";"401.96";"0";"4.53";"PIPAMAZINE";"NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL445";"NORTRIPTYLINE";"4.0";"263.38";"0";"3.83";"NORTRIPTYLINE";"CNCCC=C1c2ccccc2CCc2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4283705";"";"None";"4064.54";"None";"None";"12";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"1.62";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL404811";"DIGITONIN";"None";"1229.32";"None";"None";"DIGITONIN";"C[C@@H]1CC[C@@]2(OC1)O[C@H]1[C@@H](O)[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O[C@@H]7O[C@H](CO)C(O)[C@H](O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1413";"CICLOPIROX";"4.0";"207.27";"0";"2.44";"CICLOPIROX";"Cc1cc(C2CCCCC2)n(O)c(=O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL16";"PHENYTOIN";"4.0";"252.27";"0";"1.77";"PHENYTOIN";"O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL178";"DAUNORUBICIN";"4.0";"527.53";"2";"1.03";"DAUNORUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL595";"PIOGLITAZONE";"4.0";"356.45";"0";"3.16";"PIOGLITAZONE";"CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"SID124878660";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1619";"CLADRIBINE";"4.0";"285.69";"0";"-0.30";"CLADRIBINE";"Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL153062";"4-NONYLPHENOL";"None";"220.36";"0";"4.69";"4-NONYLPHENOL";"CCCCCCCCCc1ccc(O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL338790";"";"None";"212.21";"0";"1.31";"4-AMINO-1,8-NAPHTHALIMIDE";"Nc1ccc2c3c(cccc13)C(=O)NC2=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL720";"BENZYL ALCOHOL";"4.0";"108.14";"0";"1.18";"BENZYL ALCOHOL";"OCc1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL196";"ASCORBIC ACID";"4.0";"176.12";"0";"-1.41";"ASCORBIC ACID";"O=C1O[C@H]([C@@H](O)CO)C(O)=C1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL191";"LOSARTAN";"4.0";"422.92";"0";"4.27";"LOSARTAN";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL715";"OLANZAPINE";"4.0";"312.44";"0";"3.44";"OLANZAPINE";"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200558";"BACITRACIN";"4.0";"1422.72";"None";"None";"BACITRACIN";"CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1371125";"BENZO[E]PYRENE";"None";"252.32";"1";"5.74";"BENZO[E]PYRENE";"c1ccc2c(c1)c1cccc3ccc4cccc2c4c31";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL832";"SULFINPYRAZONE";"4.0";"404.49";"0";"3.80";"SULFINPYRAZONE";"O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL357995";"BOPINDOLOL";"2.0";"380.49";"0";"4.47";"BOPINDOLOL";"Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440193";"";"None";"1695.06";"None";"None";"15";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H]1C[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]2C[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)C2(C)C)C1(C)C)[C@@H](C)CC";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440901";"";"None";"871.92";"2";"0.15";"(S)-77";"NCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440913";"";"None";"1695.91";"None";"None";"(R,R)-50";"NCCN(CCNC(=O)c1ccc(C(=O)NCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)cc1)CCNC(=O)c1ccc(C(=O)NCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)cc1.O=C(O)C(F)(F)F";"Ki";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"3.86";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3";"NICOTINE";"4.0";"162.24";"0";"1.85";"NICOTINE";"CN1CCC[C@H]1c1cccnc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1393";"SPIRONOLACTONE";"4.0";"416.58";"0";"4.85";"SPIRONOLACTONE";"CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL443";"SULFAMETHOXAZOLE";"4.0";"253.28";"0";"1.37";"SULFAMETHOXAZOLE";"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL441687";"GLYCYRRHIZIN";"2.0";"822.94";"3";"2.25";"GLYCYRRHIZIN";"CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1236282";"THIAMPHENICOL";"2.0";"356.23";"0";"0.40";"THIAMPHENICOL";"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL411";"DIETHYLSTILBESTROL";"4.0";"268.36";"0";"4.83";"DIETHYLSTILBESTROL";"CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL388590";"BENZBROMARONE";"4.0";"424.09";"1";"5.46";"SID170465792";"CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL788";"IDOXURIDINE";"4.0";"354.10";"0";"-1.22";"IDOXURIDINE";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL16073";"PHENACETIN";"4.0";"179.22";"0";"2.04";"PHENACETIN";"CCOc1ccc(NC(C)=O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL48449";"CANTHARIDIN";"4.0";"196.20";"0";"0.64";"CANTHARIDIN";"C[C@@]12C(=O)OC(=O)[C@]1(C)[C@H]1CC[C@@H]2O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL376180";"AMINOPTERIN";"2.0";"440.42";"1";"0.24";"AMINOPTERIN";"Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL566534";"ARTEMETHER";"4.0";"298.38";"0";"2.84";"ARTEMETHER";"CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL421549";"";"None";"368.91";"1";"5.40";"(-)1";"Cn1c(COc2ccc(Cl)cc2)c(CN2CCCCC2)c2ccccc21";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL4290891";"";"None";"4064.54";"None";"None";"13";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"1.67";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4288294";"";"None";"4064.54";"None";"None";"3";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"2.02";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4283846";"";"None";"4036.53";"None";"None";"2";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CO)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C";"Ki";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"1.83";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL429005";"";"None";"1840.13";"None";"None";"20";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"95.0";"nM";"7.02";"";"";"UO_0000065";"3.82";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL1231530";"BETAMIPRON";"2.0";"193.20";"0";"0.89";"BETAMIPRON";"O=C(O)CCNC(=O)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL278172";"BENZOCAINE";"4.0";"165.19";"0";"1.45";"BENZOCAINE";"CCOC(=O)c1ccc(N)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3215298";"ABAMECTIN";"3.0";"1732.15";"None";"None";"ABAMECTIN";"CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1752";"DYPHYLLINE";"4.0";"254.25";"0";"-2.21";"DYPHYLLINE";"Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL234198";"";"None";"1890.26";"None";"None";"C23-PYY(24-36)-L31";"CC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"4.28";"None";"None";"None";"0";"CHEMBL897470";"Displacement of [125I]PYY from human NPY2 receptor in KAN-TS cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148865";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL3787713";"";"None";"1846.22";"None";"None";"18";"CCC(=O)NCCCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"3.19";"None";"None";"None";"0";"CHEMBL4478050";"Displacement of [3H]propionyl-pNPY from human NPY Y2 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477203";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL112";"ACETAMINOPHEN";"4.0";"151.16";"0";"1.35";"ACETAMINOPHEN";"CC(=O)Nc1ccc(O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL267894";"AMOBARBITAL";"4.0";"226.28";"0";"1.18";"AMOBARBITAL";"CCC1(CCC(C)C)C(=O)NC(=O)NC1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2371910";"";"None";"1710.03";"None";"None";"2B";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"3.81";"None";"None";"None";"0";"CHEMBL870718";"Displacement of [125I]NPY from human NPY2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146122";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL541";"BENZOIC ACID";"4.0";"122.12";"0";"1.38";"BENZOIC ACID";"O=C(O)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL135";"ESTRADIOL";"4.0";"272.39";"0";"3.61";"BETA-ESTRADIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909075";"";"None";"None";"None";"None";"QUINOLONE, CHEMI-LINZ ; CYANAMID";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL184";"ACYCLOVIR";"4.0";"225.21";"0";"-1.33";"ACG";"Nc1nc2c(ncn2COCCO)c(=O)[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"CARBAMAZEPINE";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1660";"RIFAPENTINE";"4.0";"877.04";"4";"5.65";"RIFAPENTINE";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1306";"TERCONAZOLE";"4.0";"532.47";"1";"4.46";"TERCONAZOLE";"CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL267744";"TICRYNAFEN";"4.0";"331.18";"0";"3.75";"TICRYNAFEN";"O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL83668";"TOLNAFTATE";"4.0";"307.42";"0";"4.95";"TOLNAFTATE";"Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL439307";"";"None";"2597.12";"None";"None";"2";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"2085.0";"nM";"5.68";"";"";"UO_0000065";"2.19";"None";"None";"None";"0";"CHEMBL747207";"Compound was tested for the displacement of [125I]-PYY(3-36) (SK-N-BE2) from Neuropeptide Y receptor type 2 in the membranes prepared from cells";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129485";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL4643863";"";"None";"951.10";"3";"-3.41";"9";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4643522";"";"None";"869.00";"3";"-4.46";"10";"N=C(N)NCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL549771";"";"None";"461.99";"1";"5.22";"23";"CC(C)(C(=O)Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1)c1ccccc1";"Ki";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL557098";"";"None";"457.57";"0";"4.57";"30";"COc1cc(NC(=O)C(C)(C)c2ccccc2)ccc1N1CCN(C(=O)c2ccccc2)CC1";"Ki";"'='";"2511.89";"nM";"5.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL551715";"";"None";"427.55";"0";"4.57";"31";"CC(C)(C(=O)Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)cc1)c1ccccc1";"Ki";"'='";"1584.89";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL557502";"";"None";"529.47";"0";"4.62";"36";"COc1cccnc1C(=O)N1CCN(c2ccc(NC(=O)C(C)(C)c3ccccc3)cc2Cl)CC1.Cl";"Ki";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL418971";"BISPHENOL A";"None";"228.29";"0";"3.42";"BISPHENOL A";"CC(C)(c1ccc(O)cc1)c1ccc(O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL30";"CIMETIDINE";"4.0";"252.35";"0";"0.60";"CIMETIDINE";"CN/C(=N\CCSCc1nc[nH]c1C)NC#N";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1697694";"AFLATOXIN";"None";"312.28";"0";"2.28";"AFLATOXIN B1";"COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1592";"QUINAPRIL";"4.0";"438.52";"0";"2.57";"QUINAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL109";"VALPROIC ACID";"4.0";"144.21";"0";"2.29";"VALPROIC ACID";"CCCC(CCC)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL437671";"";"None";"3256.82";"None";"None";"21";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H]1CSSC[C@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)NCCCCCCCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"5.2";"nM";"8.28";"";"";"UO_0000065";"2.54";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL413455";"";"None";"2362.91";"None";"None";"5";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CSSC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"822.0";"nM";"6.08";"";"";"UO_0000065";"2.58";"None";"None";"None";"0";"CHEMBL752930";"Affinity for cloned Y2 receptor using [125I]PYY as radioligand";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134468";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"2.03";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL101";"PHENYLBUTAZONE";"4.0";"308.38";"0";"3.79";"1a";"CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL47244";"PICROTOXININ";"None";"292.29";"0";"-0.06";"COCCULIN";"C=C(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL29292";"UBENIMEX";"2.0";"308.38";"0";"0.53";"UBENIMEX";"CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL413";"SIROLIMUS";"4.0";"914.19";"3";"6.18";"RAPAMYCIN";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"2.28";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL93";"ZILEUTON";"4.0";"236.30";"0";"2.73";"ZILEUTON";"CC(c1cc2ccccc2s1)N(O)C(N)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1650";"CORTISONE ACETATE";"4.0";"402.49";"0";"2.56";"CORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL302795";"TENOXICAM";"4.0";"337.38";"0";"1.64";"TENOXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"2.02";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"1.66";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1200585";"OXYMETHOLONE";"4.0";"332.48";"0";"4.40";"OXYMETHOLONE";"C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL509";"MECLOFENAMIC ACID";"4.0";"296.15";"0";"4.74";"MECLOFENAMIC ACID";"Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL104";"CLOTRIMAZOLE";"4.0";"344.85";"1";"5.38";"CLOTRIMAZOLE";"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL44814";"CARBON TETRACHLORIDE";"-1.0";"153.82";"0";"2.55";"CARBON TETRACHLORIDE";"ClC(Cl)(Cl)Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL65";"CAMPTOTHECIN";"-1.0";"348.36";"0";"2.08";"SID50104726";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL710";"FINASTERIDE";"4.0";"372.55";"0";"3.81";"FINASTERIDE";"CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL508338";"THIMEROSAL";"4.0";"404.82";"None";"None";"THIMEROSAL";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4456247";"";"None";"1706.04";"None";"None";"(2R,7R)-2";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](N)CCCC[C@@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"3.56";"None";"None";"None";"0";"CHEMBL4478050";"Displacement of [3H]propionyl-pNPY from human NPY Y2 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477203";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL123292";"CYCLOHEXIMIDE";"2.0";"281.35";"0";"1.04";"SID17389082";"C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1504";"TRIAMCINOLONE ACETONIDE";"4.0";"434.50";"0";"2.42";"TRIAMCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2307889";"";"None";"896.07";"3";"3.49";"(S)-3, BIIE0246";"N=C(N)NCCC[C@@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O";"Ki";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"9.58";"0.18";"5.10";"3.87";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1643";"RIBAVIRIN";"4.0";"244.21";"0";"-3.01";"ribavirin";"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4642752";"";"None";"803.97";"2";"-3.30";"21";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL716";"QUETIAPINE";"4.0";"383.52";"0";"2.86";"QUETIAPINE";"OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"1.58";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL121636";"";"None";"549.20";"2";"6.81";"16";"Clc1ccc(OCc2c(CN3CCC(N4CCCCC4)CC3)c3ccccc3n2CCN2CCCCC2)cc1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL4581256";"";"None";"1590.90";"None";"None";"20";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4478050";"Displacement of [3H]propionyl-pNPY from human NPY Y2 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477203";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4533775";"";"None";"1590.90";"None";"None";"22";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4478050";"Displacement of [3H]propionyl-pNPY from human NPY Y2 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477203";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4633774";"";"None";"1047.24";"None";"None";"23";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4649711";"";"None";"925.11";"3";"-3.04";"8";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4639421";"";"None";"883.03";"3";"-4.07";"11";"C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4645462";"";"None";"861.02";"3";"-4.18";"19";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4637617";"";"None";"1025.18";"None";"None";"20";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL1371";"CHLORZOXAZONE";"4.0";"169.57";"0";"1.77";"CHLORZOXAZONE";"O=c1[nH]c2cc(Cl)ccc2o1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL423192";"ANISOMYCIN";"None";"265.31";"0";"0.50";"ANISOMYCIN";"COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL40583";"3-METHYLCHOLANTHRENE";"None";"268.36";"1";"5.55";"3-METHYLCHOLANTHRENE";"Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4280250";"";"None";"4064.54";"None";"None";"14";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"1.80";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL870";"ALENDRONIC ACID";"4.0";"249.10";"1";"-1.27";"ALENDRONIC ACID";"NCCCC(O)(P(=O)(O)O)P(=O)(O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1751";"DIGOXIN";"4.0";"780.95";"3";"2.22";"DIGOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL248702";"DEXFENFLURAMINE";"4.0";"231.26";"0";"3.25";"DEXFENFLURAMINE";"CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL442";"ERGOTAMINE";"4.0";"581.67";"1";"1.99";"ERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL434063";"";"None";"495.58";"0";"4.94";"GW-1929";"CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4276961";"";"None";"4182.77";"None";"None";"PP(1-36)";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O";"Ki";"'='";"5011.87";"nM";"5.30";"";"";"UO_0000065";"1.27";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4283846";"";"None";"4036.53";"None";"None";"2";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CO)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C";"Ki";"'='";"39.81";"nM";"7.40";"";"";"UO_0000065";"1.83";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL500";"PINDOLOL";"4.0";"248.33";"0";"1.91";"PINDOLOL";"CC(C)NCC(O)COc1cccc2[nH]ccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL19224";"PAPAVERINE";"4.0";"339.39";"0";"3.86";"papaverine";"COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL748";"PRALIDOXIME CHLORIDE";"4.0";"172.62";"0";"0.32";"PRALIDOXIME CHLORIDE";"C[n+]1ccccc1/C=N/O.[Cl-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL70927";"DEFERIPRONE";"4.0";"139.15";"0";"0.40";"DEFERIPRONE";"Cc1c(O)c(=O)ccn1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL189171";"ACEMETACIN";"4.0";"415.83";"0";"3.47";"ACEMETACIN";"COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL61";"PODOFILOX";"4.0";"414.41";"0";"2.41";"PODOPHYLLOTOXIN";"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1483";"ALBENDAZOLE";"4.0";"265.34";"0";"3.24";"ALBENDAZOLE";"CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL254219";"DIGITOXIN";"4.0";"764.95";"2";"3.25";"DIGITOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1572";"NETILMICIN";"4.0";"475.59";"2";"-3.20";"NETILMICIN";"CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"SULFADIAZINE";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1255837";"DIHYDROERGOCRISTINE MESYLATE";"None";"707.85";"1";"2.72";"DIHYDROERGOCRISTINE MESYLATE";"CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL5314360";"ACONITINE";"-1.0";"645.75";"2";"0.65";"ACONITINE";"CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)[C@@]34[C@@H]5C[C@@]6(O)[C@H](OC(=O)c7ccccc7)[C@@H]5[C@@](OC(C)=O)([C@@H]([C@H](OC)[C@H]23)[C@@H]14)[C@@H](O)[C@@H]6OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1169";"AMINOSALICYLIC ACID";"4.0";"153.14";"0";"0.67";"AMINOSALICYLIC ACID";"Nc1ccc(C(=O)O)c(O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4290615";"";"None";"4064.54";"None";"None";"6";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"1.65";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4294277";"";"None";"4064.54";"None";"None";"11";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"2.512";"nM";"8.60";"";"";"UO_0000065";"2.12";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL267044";"LEVOSULPIRIDE";"2.0";"341.43";"0";"0.56";"LEVOSULPIRIDE";"CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL90555";"VINCRISTINE";"4.0";"824.97";"2";"3.52";"VINCRISTINE";"CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL27769";"STANOLONE";"2.0";"290.45";"0";"3.96";"STANOLONE";"C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1760";"TERBUTALINE";"4.0";"225.29";"0";"1.52";"TERBUTALINE";"CC(C)(C)NCC(O)c1cc(O)cc(O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200862";"METYROSINE";"4.0";"195.22";"0";"0.74";"METYROSINE";"C[C@](N)(Cc1ccc(O)cc1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL429531";"";"None";"4222.70";"None";"None";"Neuropeptide Y";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'='";"0.23";"nM";"9.64";"";"";"UO_0000065";"2.28";"None";"None";"None";"0";"CHEMBL752928";"Affinity for cloned Y2 receptor using [125I]PYY as radioligand";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134468";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL934";"METYRAPONE";"4.0";"226.28";"0";"2.64";"METYRAPONE";"CC(C)(C(=O)c1cccnc1)c1cccnc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL469";"KETOROLAC";"4.0";"255.27";"0";"2.29";"KETOROLAC";"O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL86754";"IODOQUINOL";"2.0";"396.95";"0";"3.15";"IODOQUINOL";"Oc1c(I)cc(I)c2cccnc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1390";"";"None";"344.50";"0";"4.08";"medroxyprogesterone";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL38";"TRETINOIN";"4.0";"300.44";"1";"5.60";"retinoic acid";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL562179";"";"None";"441.58";"0";"4.87";"28";"Cc1cc(NC(=O)C(C)(C)c2ccccc2)ccc1N1CCN(C(=O)c2ccccc2)CC1";"Ki";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1080298";"";"None";"444.63";"1";"6.60";"26k";"c1ccc([C@@H]2CCSC(Nc3ccc(CCNc4nc5ccccc5s4)cc3)=N2)cc1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112065";"Displacement of [125I]pig PPY from human NPY2 receptor expressed in CHOK1 cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154796";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";"";"";""
"CHEMBL428";"TROVAFLOXACIN";"4.0";"416.36";"0";"1.89";"TROVAFLOXACIN";"N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL441396";"NEUROPEPTIDE Y(NPY)";"None";"4254.70";"None";"None";"1";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"2.24";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL2370624";"";"None";"2158.50";"None";"None";"6";"CC[C@H](C)[C@H](NC(=O)[C@@H]1CNC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"4.00";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"2.02";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL625";"THIABENDAZOLE";"4.0";"201.25";"0";"2.69";"THIABENDAZOLE";"c1ccc2[nH]c(-c3cscn3)nc2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL127516";"BUTAMBEN";"4.0";"193.25";"0";"2.23";"BUTAMBEN";"CCCCOC(=O)c1ccc(N)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1168";"RAMIPRIL";"4.0";"416.52";"0";"2.38";"RAMIPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL340369";"";"None";"577.21";"2";"6.40";"17";"O=C(CN1CCC(N2CCCCC2)CC1)c1c(COc2ccc(Cl)cc2)n(CCC2CCNCC2)c2ccccc12";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL4279133";"";"None";"4064.54";"None";"None";"9";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CC(=O)O)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C";"Ki";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"1.75";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL560914";"";"None";"439.99";"1";"5.21";"18";"CC1(C(=O)Nc2ccc(N3CCN(C(=O)c4ccccc4)CC3)c(Cl)c2)CCCCC1";"Ki";"'='";"19.95";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL470495";"";"None";"529.64";"1";"2.95";"8a";"CCC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011808";"Displacement of Dy-635-pNPY from human neuropeptide Y2 receptor expressed in CHO cells coexpressing Galphaqi5 and aequorin by flow cytometric assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151759";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"1.97";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL242273";"SAFROLE";"-1.0";"162.19";"0";"2.14";"SAFROLE";"C=CCc1ccc2c(c1)OCO2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL429159";"";"None";"3340.85";"None";"None";"18";"CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]2CCCN2C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N)Cc2ccc(O)cc2)C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O";"Ki";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"2.76";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL4285633";"";"None";"4050.51";"None";"None";"17";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"2.12";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4280898";"";"None";"4050.51";"None";"None";"24";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(CC(=O)O)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C";"Ki";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"1.45";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL592100";"";"None";"1608.87";"None";"None";"(Lys(DOTA))BVD15";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL1066381";"Displacement of [125I]PYY from human neuropeptide Y2 receptor expressed in human SK-N-BE2 cells after 40 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1194";"PRILOCAINE";"4.0";"220.32";"0";"2.32";"PRILOCAINE";"CCCNC(C)C(=O)Nc1ccccc1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL564";"PROMAZINE";"4.0";"284.43";"0";"4.24";"PROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL319244";"CAFFEIC ACID PHENETHYL ESTER";"None";"284.31";"0";"2.90";"CAFFEIC ACID PHENETHYL ESTER";"O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL808";"ECONAZOLE";"4.0";"381.69";"1";"5.80";"ECONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"Ki";"'='";"10988.0";"nM";"4.96";"";"";"UO_0000065";"12.99";"0.28";"-0.84";"18.33";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL81977";"3-AMINOBENZAMIDE";"None";"136.15";"0";"0.37";"3-AMINOBENZAMIDE";"NC(=O)c1cccc(N)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL945";"AMILORIDE";"4.0";"229.63";"0";"-1.08";"AMILORIDE";"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4";"OFLOXACIN";"4.0";"361.37";"0";"1.54";"OFLOXACIN";"CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4280250";"";"None";"4064.54";"None";"None";"14";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"50.12";"nM";"7.30";"";"";"UO_0000065";"1.80";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"1.96";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"1.97";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL43882";"TRICHLOROETHANE";"None";"133.41";"0";"2.03";"TRICHLOROETHANE";"ClCC(Cl)Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL880";"FAMCICLOVIR";"4.0";"321.34";"0";"0.54";"FAMCICLOVIR";"CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL726";"FLUPHENAZINE";"4.0";"437.53";"0";"4.31";"FLUPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL290106";"BITHIONOL";"4.0";"356.06";"1";"5.86";"BITHIONOL";"Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL154";"NAPROXEN";"4.0";"230.26";"0";"3.04";"NAPROXEN";"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1493";"FLAVOXATE";"4.0";"391.47";"0";"4.41";"FLAVOXATE";"Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL556481";"";"None";"511.03";"2";"5.47";"(+/-)-26";"O=C(Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1)C(c1ccccc1)c1ccccn1";"Ki";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL193482";"ESTRIOL";"4.0";"288.39";"0";"2.58";"ESTRIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL513";"CARMUSTINE";"4.0";"214.05";"0";"1.16";"CARMUSTINE";"O=NN(CCCl)C(=O)NCCCl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL504";"DIMETHYL SULFOXIDE";"4.0";"78.14";"0";"-0.01";"DIMETHYL SULFOXIDE";"C[S+](C)[O-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL642";"ACEBUTOLOL";"4.0";"336.43";"0";"2.37";"ACEBUTOLOL";"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL340978";"BENOXAPROFEN";"4.0";"301.73";"0";"4.34";"BENOXAPROFEN";"CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4649901";"";"None";"1495.48";"None";"None";"BLEOMYCIN A2";"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL496";"HEXACHLOROPHENE";"4.0";"406.91";"1";"6.61";"HEXACHLOROPHENE";"Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1372";"OXIGLUTATIONE";"4.0";"612.64";"3";"-3.88";"GLUTATHIONE, OXIDIZED FORM";"N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201220";"DIATRIZOIC ACID";"4.0";"613.91";"1";"3.12";"DIATRIZOIC ACID";"CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1601669";"ALFACALCIDOL";"4.0";"400.65";"1";"6.59";"ALFACALCIDOL";"C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1395";"METHYLTESTOSTERONE";"4.0";"302.46";"0";"4.27";"17-METHYLTESTOSTERONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL158";"AZTREONAM";"4.0";"435.44";"0";"-1.17";"AZTREONAM";"C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL661";"ALPRAZOLAM";"4.0";"308.77";"0";"3.58";"ALPRAZOLAM";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1476898";"CADMIUM ACETATE";"None";"230.50";"None";"None";"CADMIUM ACETATE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL11359";"CISPLATIN";"4.0";"300.05";"None";"None";"SID301178";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1319362";"HOMATROPINE HYDROBROMIDE";"4.0";"356.26";"0";"1.89";"HOMATROPINE HYDROBROMIDE";"Br.CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL252556";"IDEBENONE";"4.0";"338.44";"0";"3.46";"IDEBENONE";"COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL450895";"NYSTATIN";"4.0";"926.11";"3";"0.94";"NYSTATIN";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL9";"NORFLOXACIN";"4.0";"319.34";"0";"1.27";"B";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL71";"CHLORPROMAZINE";"4.0";"318.87";"0";"4.89";"CHLORPROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL117405";"";"None";"248.33";"0";"1.91";"(S)-(-)-PINDOLOL";"CC(C)NC[C@H](O)COc1cccc2[nH]ccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1536";"ERGOCALCIFEROL";"4.0";"396.66";"1";"7.64";"ERGOCALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL124343";"";"None";"480.05";"1";"5.54";"15";"Cn1c(COc2ccc(Cl)cc2)c(C(=O)CN2CCC(N3CCCCC3)CC2)c2ccccc21";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"2.15";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL954";"ENCLOMIPHENE";"3.0";"405.97";"1";"6.56";"CLOMIPHENE";"CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL26260";"BETA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"BETA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL871";"ETIDRONIC ACID";"4.0";"206.03";"0";"-0.99";"ETIDRONATE";"CC(O)(P(=O)(O)O)P(=O)(O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200623";"ETHYLESTRENOL";"4.0";"288.48";"1";"5.09";"ETHYLESTRENOL";"CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1024";"IFOSFAMIDE";"4.0";"261.09";"0";"1.88";"IFOSFAMIDE";"O=P1(NCCCl)OCCCN1CCCl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200993";"GALLAMINE TRIETHIODIDE";"4.0";"891.54";"2";"5.45";"GALLAMINE TRIETHIODIDE";"CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"2.10";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL545";"ALCOHOL";"4.0";"46.07";"0";"0.00";"ETHANOL";"CCO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL838";"BENAZEPRIL";"4.0";"424.50";"0";"2.57";"BENAZEPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL116";"AMPRENAVIR";"4.0";"505.64";"1";"2.40";"AMPRENAVIR";"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL457";"GEMFIBROZIL";"4.0";"250.34";"0";"3.57";"GEMFIBROZIL";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL87285";"ANDROSTERONE";"None";"290.45";"0";"3.96";"ANDROSTERONE";"C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1774344";"";"None";"1076.26";"3";"7.39";"66, UR-MK131";"CN(C)c1ccc(/C=C/C=C/c2sc3ccccc3[n+]2CCCC(=O)NCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)cc1.O=C([O-])C(F)(F)F";"Ki";"'>'";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1777149";"Displacement of Dy-635-pNPY from human Y2R expressed in CHO cells by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1773009";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL265426";"";"None";"2767.34";"None";"None";"4";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"3406.0";"nM";"5.47";"";"";"UO_0000065";"1.98";"None";"None";"None";"0";"CHEMBL747207";"Compound was tested for the displacement of [125I]-PYY(3-36) (SK-N-BE2) from Neuropeptide Y receptor type 2 in the membranes prepared from cells";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129485";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"2.19";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"2.01";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL762";"OXYMETAZOLINE";"4.0";"260.38";"0";"2.85";"OXYMETAZOLINE";"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4281120";"";"None";"4022.46";"None";"None";"20";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"1.64";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4282616";"";"None";"4050.51";"None";"None";"26";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"1.38";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4282168";"";"None";"1737.99";"None";"None";"34";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"4.90";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4287469";"";"None";"4064.54";"None";"None";"15";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C)CC(C)C";"Ki";"'='";"50.12";"nM";"7.30";"";"";"UO_0000065";"1.80";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL54126";"NEOSTIGMINE BROMIDE";"4.0";"303.20";"0";"1.94";"NEOSTIGMINE BROMIDE";"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4277590";"";"None";"4052.50";"None";"None";"39";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"2.30";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL600325";"PROSCILLARIDIN";"4.0";"530.66";"1";"3.01";"PROSCILLARIDIN";"C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL44618";"CHLOROFORM";"4.0";"119.38";"0";"1.99";"CHLOROFORM";"ClC(Cl)Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL862";"GUANFACINE";"4.0";"246.10";"0";"1.55";"GUANFACINE";"N=C(N)NC(=O)Cc1c(Cl)cccc1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1456";"MYCOPHENOLATE MOFETIL";"4.0";"433.50";"0";"2.52";"MYCOPHENOLATE MOFETIL";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909055";"COBALTOUS CHLORIDE";"4.0";"129.84";"None";"None";"COBALT (II) CHLORIDE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1535";"HYDROXYCHLOROQUINE";"4.0";"335.88";"0";"3.78";"HYDROXYCHLOROQUINE";"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1491";"AMLODIPINE";"4.0";"408.88";"0";"2.27";"AMLODIPINE";"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL539730";"";"None";"399.92";"0";"4.29";"3";"CC(C)(C)C(=O)Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1";"Ki";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL552393";"";"None";"413.95";"0";"4.31";"15";"CN(C(=O)C(C)(C)C)c1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1";"Ki";"'='";"2511.89";"nM";"5.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL550504";"";"None";"425.96";"0";"4.82";"17";"O=C(Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1)C1CCCCC1";"Ki";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL561313";"";"None";"434.93";"0";"3.88";"25";"O=C(Cc1ccccn1)Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1";"Ki";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL241694";"ETHISTERONE";"3.0";"312.45";"0";"3.88";"ETHISTERONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL139835";"CYPROTERONE ACETATE";"4.0";"416.95";"0";"4.61";"CYPROTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL19215";"METERGOLINE";"4.0";"403.53";"0";"4.06";"METERGOLINE";"CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200604";"TROPICAMIDE";"4.0";"284.36";"0";"2.21";"TROPICAMIDE";"CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL137";"METRONIDAZOLE";"4.0";"171.16";"0";"0.09";"METRONIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CCO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL622";"ETODOLAC";"4.0";"287.36";"0";"3.38";"ETODOLAC";"CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL54";"HALOPERIDOL";"4.0";"375.87";"0";"4.43";"HALOPERIDOL";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL37161";"FENBENDAZOLE";"2.0";"299.36";"0";"3.89";"FENBENDAZOLE";"COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL498";"CHLORPROPAMIDE";"4.0";"276.75";"0";"1.74";"CHLORPROPAMIDE";"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2108139";"POVIDONE";"4.0";"None";"None";"None";"POLYVINYLPYRROLIDONE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL93645";"ACECLOFENAC";"4.0";"354.19";"0";"3.91";"ACECLOFENAC";"O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200431";"GADOPENTETATE DIMEGLUMINE";"4.0";"742.79";"None";"None";"GADOPENTETATE DIMEGLUMINE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1771";"CLOPIDOGREL";"4.0";"321.83";"0";"3.67";"CLOPIDOGREL";"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"CLOZAPINE";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL562725";"";"None";"510.04";"2";"6.07";"22";"O=C(Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1)C(c1ccccc1)c1ccccc1";"Ki";"'='";"6.31";"nM";"8.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1537";"AZLOCILLIN";"4.0";"461.50";"0";"0.09";"AZLOCILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL277474";"ANTIPYRINE";"4.0";"188.23";"0";"1.48";"ANTIPYRINE";"Cc1cc(=O)n(-c2ccccc2)n1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL36994";"ANIRACETAM";"2.0";"219.24";"0";"1.46";"ANIRACETAM";"COc1ccc(C(=O)N2CCCC2=O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL833";"TICLOPIDINE";"4.0";"263.79";"0";"3.96";"TICLOPIDINE";"Clc1ccccc1CN1CCc2sccc2C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1411979";"METHAPYRILENE";"4.0";"261.39";"0";"2.71";"METHAPYRILENE";"CN(C)CCN(Cc1cccs1)c1ccccn1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL407030";"";"None";"1281.13";"None";"None";"GAMMA-CYCLODEXTRIN";"OC[C@H]1OC2C3[C@@H](CO)OC(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)C(OC1[C@H](O)[C@H]2O)O[C@@H]9CO)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)[C@H](O)[C@H]3O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL741";"LAMOTRIGINE";"4.0";"256.10";"0";"2.01";"LAMOTRIGINE";"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL691";"ETHINYL ESTRADIOL";"4.0";"296.41";"0";"3.61";"Ethinylestradiol";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL552112";"";"None";"530.98";"2";"5.63";"35";"CC(C)(C(=O)Nc1ccc(N2CCN(C(=O)c3ncccc3C(F)(F)F)CC2)c(Cl)c1)c1ccccc1";"Ki";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL989";"FLUOCINOLONE ACETONIDE";"4.0";"452.49";"0";"2.37";"FLUOCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL407";"FLUMAZENIL";"4.0";"303.29";"0";"1.77";"FLUMAZENIL";"CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1062";"HYDROXYPROGESTERONE";"2.0";"330.47";"0";"3.84";"17alpha-OH progesterone";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL291338";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"4.0";"351.02";"1";"5.26";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL567";"PERPHENAZINE";"4.0";"403.98";"0";"3.94";"PERPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL597";"PHENTOLAMINE";"4.0";"281.36";"0";"2.84";"PHENTOLAMINE";"Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL192";"SILDENAFIL";"4.0";"474.59";"0";"1.61";"SILDENAFIL";"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL129";"ZIDOVUDINE";"4.0";"267.24";"0";"-0.20";"AZT";"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL14192";"BENZYLIMIDAZOLE";"None";"158.20";"0";"1.93";"1-BENZYLIMIDAZOLE";"c1ccc(Cn2ccnc2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1499";"CORTISONE";"3.0";"360.45";"0";"1.99";"CORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1460";"DIDANOSINE";"4.0";"236.23";"0";"-0.21";"DIDANOSINE";"O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4858915";"";"None";"1093.26";"None";"None";"16";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL683";"CLOFIBRIC ACID";"2.0";"214.65";"0";"2.58";"CLOFIBRIC ACID";"CC(C)(Oc1ccc(Cl)cc1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL72";"DESIPRAMINE";"4.0";"266.39";"0";"3.53";"DESIPRAMINE";"CNCCCN1c2ccccc2CCc2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL499";"TIMOLOL";"4.0";"316.43";"0";"0.50";"TIMOLOL";"CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL6273";"FLEROXACIN";"2.0";"369.34";"0";"1.70";"FLEROXACIN";"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL139";"DICLOFENAC";"4.0";"296.15";"0";"4.36";"DICLOFENAC";"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL241105";"";"None";"1737.01";"None";"None";"12";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1cccc(N)c1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"4.83";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL386823";"";"None";"1206.46";"None";"None";"1";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)CC";"Ki";"'='";"11.3";"nM";"7.95";"";"";"UO_0000065";"6.59";"None";"None";"None";"0";"CHEMBL752928";"Affinity for cloned Y2 receptor using [125I]PYY as radioligand";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134468";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL1054";"TRICHLORMETHIAZIDE";"4.0";"380.66";"0";"0.82";"TRICHLORMETHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL408";"TROGLITAZONE";"4.0";"441.55";"0";"4.37";"troglitazone";"Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1288285";"";"None";"534.07";"2";"6.98";"31";"CC(C)(C(=O)Nc1ccc(N2CCC3(CCN(CC4CC4)C3)CC2)c(Cl)c1)c1cccc(C(F)(F)F)c1";"Ki";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1287898";"";"None";"417.91";"0";"4.43";"5, amide";"CC(C)(C)C(=O)Nc1ccc(N2CCN(C(=O)c3cccc(F)c3)CC2)c(Cl)c1";"Ki";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL742";"KETAMINE";"4.0";"237.73";"0";"2.90";"KETAMINE";"CNC1(c2ccccc2Cl)CCCCC1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL558551";"";"None";"258.23";"0";"0.09";"(+)-THALIDOMIDE";"O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL118";"CELECOXIB";"4.0";"381.38";"0";"3.51";"1";"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1567463";"CHOLINE ALFOSCERATE";"None";"257.22";"0";"-1.45";"CHOLINE ALFOSCERATE";"C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL457299";"MACROGOL";"4.0";"62.07";"0";"-1.03";"ETHYLENE GLYCOL";"OCCO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL495778";"PENICILLIC ACID";"None";"170.16";"0";"0.34";"PENICILLIC ACID";"C=C(C)C1(O)OC(=O)C=C1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL765";"GUANETHIDINE";"4.0";"198.31";"0";"0.74";"GUANETHIDINE";"N=C(N)NCCN1CCCCCCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL427216";"GLICLAZIDE";"4.0";"323.42";"0";"1.63";"GLICLAZIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL5314404";"AJMALINE";"3.0";"326.44";"0";"1.55";"AJMALINE";"CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)c5ccccc5[C@]45C[C@@H]([C@@H]2[C@H]5O)N3[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1515611";"BROMISOVALUM";"2.0";"223.07";"0";"0.60";"BROMISOVALUM";"CC(C)C(Br)C(=O)NC(N)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1235242";"";"None";"183.18";"0";"0.78";"4-FLUORO-L-PHENYLALANINE";"N[C@@H](Cc1ccc(F)cc1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1289";"HALOPROGIN";"4.0";"361.39";"0";"4.42";"HALOPROGIN";"Clc1cc(Cl)c(OCC#CI)cc1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL34139";"GENACONAZOLE";"None";"331.34";"0";"0.88";"GENACONAZOLE (RR(+) ISOMER)";"C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL15511";"ENROFLOXACIN";"2.0";"359.40";"0";"2.32";"ENROFLOXACIN";"CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1467";"ALLOPURINOL";"4.0";"136.11";"0";"0.06";"ALLOPURINOL";"Oc1ncnc2[nH]ncc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1370561";"AMINOPHYLLINE";"4.0";"420.43";"0";"-1.04";"AMINOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL12089";"BERBERINE CHLORIDE";"1.0";"371.82";"0";"3.10";"BERBERINE CHLORIDE";"COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL529";"AZITHROMYCIN";"4.0";"749.00";"2";"1.90";"AZITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1082";"AMOXICILLIN";"4.0";"365.41";"0";"0.02";"AMOXICILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL437290";"";"None";"1721.99";"None";"None";"14";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"4.77";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL397528";"";"None";"1737.01";"None";"None";"13";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccc(N)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"4.73";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL268200";"";"None";"1617.89";"None";"None";"4";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"4.06";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL332347";"";"None";"473.58";"0";"2.38";"BIBP-3226";"NC(N)=NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL4874445";"";"None";"1180.34";"None";"None";"30";"N=C(N)NCCC[C@@H]1NC(=O)CCC(=O)NCCCNC(=O)NC(=N)NCCC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4874850";"";"None";"1198.36";"None";"None";"29";"N=C(N)NCCC[C@H](NC(=O)CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)NC(=O)NCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL567597";"ARTEMISININ";"4.0";"282.34";"0";"2.39";"ARTEMISININ";"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2220427";"ERYTHROMYCIN PROPIONATE";"4.0";"790.00";"2";"2.75";"ERYTHROMYCIN PROPIONATE";"CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL156455";"1,1-DICHLOROETHENE";"None";"96.94";"0";"1.94";"1,1-DICHLOROETHENE";"C=C(Cl)Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL310555";"OXYQUINOLINE";"-1.0";"145.16";"0";"1.94";"OXYQUINOLINE";"Oc1cccc2cccnc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1790041";"RANITIDINE";"4.0";"314.41";"0";"1.46";"RANITIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1276308";"MIFEPRISTONE";"4.0";"429.60";"1";"5.41";"MIFEPRISTONE";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL76904";"TYRPHOSTIN 23";"None";"186.17";"0";"1.53";"TYRPHOSTIN A23";"N#CC(C#N)=Cc1ccc(O)c(O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL998";"LORATADINE";"4.0";"382.89";"0";"4.89";"LORATADINE";"CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL58";"MITOXANTRONE";"4.0";"444.49";"1";"-0.14";"MITOXANTRONE";"O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909079";"STANNOUS FLUORIDE";"4.0";"156.71";"None";"None";"STANNOUS FLUORIDE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2107797";"NORGESTREL";"4.0";"312.45";"0";"3.88";"NORGESTREL";"C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL865";"VALDECOXIB";"4.0";"314.37";"0";"2.96";"VALDECOXIB";"Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL395110";"MEPAZINE";"4.0";"310.47";"0";"4.63";"MEPAZINE";"CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL179166";"SODIUM ORTHOVANAD";"None";"183.91";"None";"None";"SODIUM ORTHOVANADATE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1517";"OXYTETRACYCLINE";"4.0";"460.44";"1";"-1.24";"OXYTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1463";"FLUCYTOSINE";"4.0";"129.09";"0";"-0.51";"5-FC";"Nc1nc(=O)[nH]cc1F";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1167";"SPECTINOMYCIN";"4.0";"332.35";"0";"-2.93";"SPECTINOMYCIN";"CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909080";"STRONTIUM CHLORIDE HEXAHYDRATE";"None";"266.62";"None";"None";"STRONTIUM CHLORIDE HEXAHYDRATE";"O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL772";"RESERPINE";"4.0";"608.69";"1";"4.17";"RESERPINE";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1221512";"";"None";"559.80";"1";"1.75";"L-744832";"CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL193";"NIFEDIPINE";"4.0";"346.34";"0";"2.18";"NIFEDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL707";"DOXAZOSIN";"4.0";"451.48";"0";"1.72";"DOXAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL502620";"ACLARUBICIN";"3.0";"811.88";"2";"3.16";"ACLARUBICIN";"CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL429023";"ROTENONE";"None";"394.42";"0";"3.70";"ROTENONE";"C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL211501";"ANTIMYCIN A";"None";"548.63";"1";"3.48";"ANTIMYCIN A";"CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1403281";"ERGOCRYPTINE";"None";"575.71";"1";"2.43";"ALPHA-ERGOCRYPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1077";"BROMFENAC";"4.0";"334.17";"0";"2.89";"BROMFENAC";"Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL83";"TAMOXIFEN";"4.0";"371.52";"1";"6.00";"TAMOXIFEN";"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"1.91";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1454946";"FLUBENDAZOLE";"2.0";"313.29";"0";"3.11";"FLUBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL164290";"N-NITROSODIETHYLAMINE";"None";"102.14";"0";"1.01";"N-NITROSODIETHYLAMINE";"CCN(CC)N=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL372795";"STREPTOMYCIN";"4.0";"581.58";"3";"-8.16";"streptomycin";"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2252949";"(-)-CAMPHOR";"None";"152.24";"0";"2.40";"L-CAMPHOR";"CC1(C)[C@H]2CC[C@]1(C)C(=O)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL18797";"SULINDAC SULFIDE";"-1.0";"340.42";"1";"5.35";"SULINDAC SULFIDE";"CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL62193";"SULFADIMETHOXINE";"4.0";"310.34";"0";"0.88";"SULFADIMETHOXINE";"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1144";"PRAVASTATIN";"4.0";"424.53";"0";"2.44";"PRAVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL44657";"ETOPOSIDE";"4.0";"588.56";"2";"1.34";"ETOPOSIDE";"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL31";"GATIFLOXACIN";"4.0";"375.40";"0";"1.98";"Gatifloxacin";"COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL273348";"TOSUFLOXACIN";"2.0";"404.35";"0";"2.04";"TOSUFLOXACIN";"NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1081469";"";"None";"354.50";"0";"4.47";"1a";"c1ccc2sc(NCCc3ccc(NC4=NCCS4)cc3)nc2c1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112065";"Displacement of [125I]pig PPY from human NPY2 receptor expressed in CHOK1 cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154796";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";"";"";""
"CHEMBL2371911";"";"None";"1724.06";"None";"None";"4A";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"3.64";"None";"None";"None";"0";"CHEMBL870718";"Displacement of [125I]NPY from human NPY2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146122";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1231107";"CYROMAZINE";"2.0";"166.19";"0";"-0.39";"CYROMAZINE";"Nc1nc(N)nc(NC2CC2)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL517712";"ATROPINE";"4.0";"289.38";"0";"1.93";"ATROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1458880";"CADMIUM DICHLORIDE";"None";"183.32";"None";"None";"CADMIUM CHLORIDE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909068";"";"None";"None";"None";"None";"MC 258717";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4634913";"";"None";"1097.25";"None";"None";"25";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL2440923";"";"None";"1085.32";"None";"None";"(R,R)-1b";"N/C(=N/C(=O)CCCCCCC(=O)/N=C(\N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2441114";"";"None";"714.79";"2";"2.42";"(R)-39";"N=C(N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(=O)NCCCCN)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL234926";"ALLYL ALCOHOL";"None";"58.08";"0";"0.16";"ALLYL ALCOHOL";"C=CCO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL86";"METOCLOPRAMIDE";"4.0";"299.80";"0";"2.00";"METOCLOPRAMIDE";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1566956";"TROXIPIDE";"2.0";"294.35";"0";"1.19";"TROXIPIDE";"COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL23";"DILTIAZEM";"4.0";"414.53";"0";"3.37";"DILTIAZEM";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1687";"TUBOCURARINE CHLORIDE";"None";"645.20";"2";"6.70";"D-TUBOCURARINE CHLORIDE";"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201195";"CEFMETAZOLE";"4.0";"471.55";"1";"-0.73";"CEFMETAZOLE";"CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL238071";"VINDESINE";"4.0";"753.94";"1";"2.73";"VINDESINE";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL27577";"SALICYLAMIDE";"2.0";"137.14";"0";"0.49";"SALICYLAMIDE";"NC(=O)c1ccccc1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL189";"MILRINONE";"4.0";"211.22";"0";"1.62";"MILRINONE";"Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440899";"";"None";"2078.42";"None";"None";"(R,S)-57";"NCCN(CCNC(=O)CCC(=O)NCCCCCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O)CCNC(=O)CCC(=O)NCCCCCCNC(=O)/N=C(\N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"Ki";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"3.60";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440185";"";"None";"1673.95";"None";"None";"8";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"7.1";"nM";"8.15";"";"";"UO_0000065";"4.87";"None";"None";"None";"0";"CHEMBL2447450";"Binding affinity to human Y2 receptor expressed in human SMS-KAN cells by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2440194";"";"None";"1661.98";"None";"None";"16";"CCCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1909064";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"None";"None";"None";"None";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201146";"NORETHINDRONE ACETATE";"4.0";"340.46";"0";"4.06";"NORETHINDRONE ACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL711";"PHENINDIONE";"4.0";"222.24";"0";"2.85";"PHENINDIONE";"O=C1c2ccccc2C(=O)C1c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL635";"PREDNISONE";"4.0";"358.43";"0";"1.77";"PREDNISONE";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL672";"FENOFIBRATE";"4.0";"360.84";"0";"4.68";"FENOFIBRATE";"CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440918";"";"None";"800.88";"2";"1.72";"(R)-40";"N=C(N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(=O)NCCCCNC(=O)NCCN)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440937";"";"None";"803.84";"2";"1.24";"(R)-33";"N=C(N)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440929";"";"None";"473.58";"1";"2.59";"(S)-1a";"N=C(N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1064";"SIMVASTATIN";"4.0";"418.57";"0";"4.59";"SIMVASTATIN";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1230333";"";"None";"170.23";"0";"2.16";"4-(2-THIENYL)BUTYRIC ACID";"O=C(O)CCCc1cccs1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2392022";"";"None";"2798.17";"None";"None";"porcine";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'='";"0.12";"nM";"9.92";"";"";"UO_0000065";"3.55";"None";"None";"None";"0";"CHEMBL2395092";"Displacement of [125I]Peptide YY from neuropeptide Y receptor type 2 in human KAN-TS cells after 2 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL32749";"FERULATE";"-1.0";"194.19";"0";"1.50";"FERULIC ACID";"COc1cc(/C=C/C(=O)O)ccc1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2371910";"";"None";"1710.03";"None";"None";"2B";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"3.85";"None";"None";"None";"0";"CHEMBL870718";"Displacement of [125I]NPY from human NPY2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146122";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL728";"PROCHLORPERAZINE";"4.0";"373.95";"0";"4.58";"PROCHLORPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL12";"DIAZEPAM";"4.0";"284.75";"0";"3.15";"Diazepam";"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909083";"ZIRCONIUM(IV) CHLORIDE";"None";"233.04";"None";"None";"ZIRCONIUM(IV) CHLORIDE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL332347";"";"None";"473.58";"0";"2.38";"1a; BIBP3226";"NC(N)=NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3750366";"Displacement of Cy5-pNPY from human NPY2R expressed in CHO cells by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";"";"";""
"CHEMBL508974";"";"None";"602.69";"2";"2.28";"6";"CCOC(=O)CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3750366";"Displacement of Cy5-pNPY from human NPY2R expressed in CHO cells by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3746864";"";"None";"787.72";"2";"1.68";"36";"NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3750366";"Displacement of Cy5-pNPY from human NPY2R expressed in CHO cells by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2440931";"";"None";"761.80";"2";"1.71";"(S)-24";"NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440924";"";"None";"1285.56";"None";"None";"(R,R)-1c";"NCCN(CCNC(=O)CCCC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1)CCNC(=O)CCCC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"Ki";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"4.83";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL428017";"";"None";"1787.11";"None";"None";"190, AcPYY (24-36)-L31";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"4.64";"None";"None";"None";"1";"CHEMBL3106329";"Binding affinity to NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL698";"TETRACAINE";"4.0";"264.37";"0";"2.62";"TETRACAINE";"CCCCNc1ccc(C(=O)OCCN(C)C)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1076211";"TOLPERISONE";"3.0";"245.37";"0";"3.30";"TOLPERISONE";"Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1110";"ALOSETRON";"4.0";"294.36";"0";"2.41";"ALOSETRON";"Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL45245";"";"None";"195.22";"0";"2.68";"6(5H)-PHENANTHRIDINONE";"O=c1[nH]c2ccccc2c2ccccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201193";"LEVOBUPIVACAINE";"4.0";"288.44";"0";"3.90";"LEVOBUPIVACAINE";"CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL783";"NATEGLINIDE";"4.0";"317.43";"0";"3.26";"NATEGLINIDE";"CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL14";"CARBACHOL";"4.0";"182.65";"0";"-0.21";"CARBACHOL";"C[N+](C)(C)CCOC(N)=O.[Cl-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440905";"";"None";"1014.08";"2";"-0.83";"(S)-79";"NCCNC(=O)CCC(=O)NCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL203266";"TRIMETAZIDINE";"4.0";"266.34";"0";"1.12";"TRIMETAZIDINE";"COc1ccc(CN2CCNCC2)c(OC)c1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1747";"TOBRAMYCIN";"4.0";"467.52";"2";"-6.30";"TOBRAMYCIN";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1196581";"";"None";"493.01";"0";"4.62";"1";"COc1cccnc1C(=O)N1CCN(c2ccc(NC(=O)C(C)(C)c3ccccc3)cc2Cl)CC1";"Ki";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1365675";"AMITRAZ";"2.0";"293.41";"0";"4.87";"AMITRAZ";"Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3104224";"";"None";"1108.31";"None";"None";"UR-PLN196";"CCC(=O)NCCNC(=O)CCCC(=O)NC(=N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O";"Ki";"'='";"9.9";"nM";"8.00";"";"";"UO_0000065";"7.22";"None";"None";"None";"0";"CHEMBL3107078";"Binding affinity to NPYY2 receptor (unknown origin) preincubated for 20 mins";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1455";"ALTRETAMINE";"4.0";"210.28";"0";"0.07";"ALTRETAMINE";"CN(C)c1nc(N(C)C)nc(N(C)C)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1560";"CAPTOPRIL";"4.0";"217.29";"0";"0.63";"CAPTOPRIL";"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL177756";"FLUORESCEIN";"None";"332.31";"0";"3.97";"FLUORESCEIN";"O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL9514";"NOCODAZOLE";"2.0";"301.33";"0";"3.03";"nocodazole";"COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL44884";"ETHAMBUTOL";"4.0";"204.31";"0";"-0.29";"ETHAMBUTOL";"CC[C@@H](CO)NCCN[C@@H](CC)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1566";"ACARBOSE";"4.0";"645.61";"3";"-8.56";"ACARBOSE";"C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1729";"CISAPRIDE";"4.0";"465.95";"0";"3.36";"1";"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL316561";"PROGLUMIDE";"4.0";"334.42";"0";"2.30";"PROGLUMIDE";"CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL424";"SALICYLIC ACID";"4.0";"138.12";"0";"1.09";"Salicylic acid";"O=C(O)c1ccccc1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL462547";"URETHANE";"4.0";"89.09";"0";"0.10";"URETHANE";"CCOC(N)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL165";"RESVERATROL";"3.0";"228.25";"0";"2.97";"SID458391";"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL559147";"Y-27632";"None";"247.34";"0";"2.17";"Y-27632";"C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL558";"MEXILETINE";"4.0";"179.26";"0";"2.03";"MEXILETINE";"Cc1cccc(C)c1OCC(C)N";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL190";"THEOPHYLLINE";"4.0";"180.17";"0";"-1.04";"THEOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1651906";"STREPTOZOCIN";"4.0";"265.22";"0";"-2.89";"STREPTOZOTOCIN";"CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL521589";"BAMBUTEROL";"3.0";"367.45";"0";"2.23";"BAMBUTEROL";"CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL38737";"THIOACETAMIDE";"None";"75.14";"0";"0.91";"THIOACETAMIDE";"CC(=N)S";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL386630";"TESTOSTERONE";"4.0";"288.43";"0";"3.88";"TESTOSTERONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440915";"";"None";"1816.02";"None";"None";"(S,S)-51, UR-MEK388";"NCCN(CCNC(=O)c1ccc(C(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)cc1)CCNC(=O)c1ccc(C(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)cc1.O=C(O)C(F)(F)F";"Ki";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"3.44";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL527";"PIROXICAM";"4.0";"331.35";"0";"1.58";"PIROXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL267633";"NEUROPEPTIDE-Y";"None";"4253.71";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"2.24";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"1.99";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL2440898";"";"None";"1740.02";"None";"None";"(R,R)-54";"N=C(N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(=O)NCCCCNC(=O)CNC(=O)CCC(=O)NCCN(CCN)CCNC(=O)CCC(=O)NCC(=O)NCCCCNC(=O)NCc2ccc(CNC(=O)[C@@H](CCCNC(=N)N)NC(=O)C(c3ccccc3)c3ccccc3)cc2)cc1.O=C(O)C(F)(F)F";"Ki";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"3.47";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440907";"";"None";"1085.16";"2";"-1.33";"(S)-80";"NCCC(=O)NCCNC(=O)CCC(=O)NCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2110365";"";"None";"2352.78";"None";"None";"6, GR-231118";"CC[C@H](C)[C@H](N)C(=O)N[C@H]1CCC(=O)NC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)CC)CCC(=O)NC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@@H]2CCCN2C1=O";"Ki";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"3.09";"None";"None";"None";"0";"CHEMBL752928";"Affinity for cloned Y2 receptor using [125I]PYY as radioligand";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134468";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL2370635";"";"None";"2238.55";"None";"None";"13";"CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H]2CNC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](C)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc3ccc(O)cc3)CCC(=O)N2)CCCCNC(=O)CC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC1=O";"Ki";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"4.25";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"2.19";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1201139";"MEGESTROL ACETATE";"4.0";"384.52";"0";"4.58";"MEGESTROL ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL95";"TACRINE";"4.0";"198.27";"0";"2.70";"4";"Nc1c2c(nc3ccccc13)CCCC2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1020";"TOLMETIN";"4.0";"257.29";"0";"2.19";"TOLMETIN";"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4877802";"";"None";"976.15";"3";"-3.38";"19";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL437487";"";"None";"1783.10";"None";"None";"2";"CSc1ncccc1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'='";"11.0";"nM";"7.96";"";"Antagonist";"UO_0000065";"4.46";"None";"None";"None";"0";"CHEMBL914220";"Displacement of [125I]PYY from human NPY2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147158";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"ANTAGONIST";""
"CHEMBL415690";"BETADEX";"3.0";"1134.99";"None";"None";"BETA CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL403";"SULBACTAM";"4.0";"233.24";"0";"-0.79";"SULBACTAM";"CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440909";"";"None";"960.02";"2";"0.19";"(S)-81";"NCCOCCOCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440926";"";"None";"1655.93";"None";"None";"(R,R)-46";"NCCN(CCNC(=O)CCCCC(=O)NCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1)CCNC(=O)CCCCC(=O)NCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"3.89";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440936";"";"None";"659.71";"2";"3.14";"(R)-31";"NCCCCNC(=O)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1774204";"";"None";"529.65";"2";"2.05";"(R)-2, BIBO3304";"N=C(N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL141";"LAMIVUDINE";"4.0";"229.26";"0";"-0.59";"3TC";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440900";"";"None";"871.92";"2";"0.15";"(R)-77";"NCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL157138";"LISURIDE";"4.0";"338.46";"0";"2.84";"LISURIDE";"CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL24";"ATENOLOL";"4.0";"266.34";"0";"0.45";"ATENOLOL";"CC(C)NCC(O)COc1ccc(CC(N)=O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1712923";"IRSOGLADINE MALEATE";"1.0";"372.17";"0";"2.01";"IRSOGLADINE MALEATE";"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201237";"LEVOBUNOLOL";"4.0";"291.39";"0";"2.33";"LEVOBUNOLOL";"CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1288227";"";"None";"495.98";"1";"5.03";"27";"CC(C)(C(=O)Nc1ccc(N2CCC(NCC3CC3)CC2)c(Cl)c1)c1nccc(C(F)(F)F)n1";"Ki";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2440914";"";"None";"1816.02";"None";"None";"(R,R)-51, UR-MK188";"NCCN(CCNC(=O)c1ccc(C(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)cc1)CCNC(=O)c1ccc(C(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)cc1.O=C(O)C(F)(F)F";"Ki";"'='";"920.0";"nM";"6.04";"";"";"UO_0000065";"3.55";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440917";"";"None";"1653.97";"None";"None";"(R,R)-53";"N=C(N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(=O)NCCCCNC(=O)CCCC(=O)NCCN(CCN)CCNC(=O)CCCC(=O)NCCCCNC(=O)NCc2ccc(CNC(=O)[C@@H](CCCNC(=N)N)NC(=O)C(c3ccccc3)c3ccccc3)cc2)cc1.O=C(O)C(F)(F)F";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440927";"";"None";"1719.93";"None";"None";"(R,R)-47";"NCCN(CCNC(=O)CCC(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1)CCNC(=O)CCC(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"Ki";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"3.58";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"1.89";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1016";"CANDESARTAN";"3.0";"440.46";"0";"4.03";"CANDESARTAN";"CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL599";"MELOXICAM";"4.0";"351.41";"0";"1.95";"MELOXICAM";"Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2370634";"";"None";"2213.54";"None";"None";"11";"CC[C@H](C)[C@H](NC(=O)[C@@H]1CNC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"4.05";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1069";"VALSARTAN";"4.0";"435.53";"0";"4.16";"VALSARTAN";"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1288257";"";"None";"427.98";"0";"4.23";"(+/-)-29";"CCC(C(=O)Nc1ccc(N2CCC(NCC3CC3)CC2)c(Cl)c1)c1ncccn1";"Ki";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1287954";"";"None";"385.94";"0";"4.65";"3, amine";"CC(C)(C)C(=O)Nc1ccc(N2CCN(Cc3ccccc3)CC2)c(Cl)c1";"Ki";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL410166";"";"None";"2324.82";"None";"None";"8";"CC[C@H](C)[C@H](N)C(=O)N[C@H]1CCC(=O)NC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](NC(=O)[C@@H](N)[C@@H](C)CC)CCC(=O)NC[C@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@@H]2CCCN2C1=O";"Ki";"'='";"624.0";"nM";"6.21";"";"";"UO_0000065";"2.67";"None";"None";"None";"0";"CHEMBL752930";"Affinity for cloned Y2 receptor using [125I]PYY as radioligand";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134468";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL238533";"";"None";"1889.20";"None";"None";"2";"CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"4.51";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL2440196";"";"None";"1661.98";"None";"None";"18";"CCCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'='";"708.0";"nM";"6.15";"";"";"UO_0000065";"3.70";"None";"None";"None";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440195";"";"None";"1676.01";"None";"None";"17";"CCCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'='";"217.0";"nM";"6.66";"";"";"UO_0000065";"3.98";"None";"None";"None";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440187";"";"None";"1656.96";"None";"None";"10";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1288016";"";"None";"488.08";"1";"6.57";"13";"O=C(Nc1ccc(N2CCC(N3CCCCC3)CC2)c(Cl)c1)C(c1ccccc1)c1ccccc1";"Ki";"'='";"50.12";"nM";"7.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1288169";"";"None";"428.02";"1";"5.47";"22";"CC(C)CNC1CCN(c2ccc(NC(=O)C(C)(C)c3ccccc3)cc2Cl)CC1";"Ki";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL266730";"";"None";"2262.61";"None";"None";"4";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"3.76";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL2371908";"";"None";"1708.01";"None";"None";"7";"CC(C)C[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O";"Ki";"'='";"890.0";"nM";"6.05";"";"";"UO_0000065";"3.54";"None";"None";"None";"0";"CHEMBL870718";"Displacement of [125I]NPY from human NPY2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146122";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL436630";"";"None";"1771.45";"None";"None";"15";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccc(N)cc1Cl)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"4.64";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL397527";"";"None";"1503.73";"None";"None";"7";"CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"4.11";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"18.7";"nM";"7.73";"";"";"UO_0000065";"1.82";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1288049";"";"None";"452.04";"1";"5.86";"15";"O=C(Nc1ccc(N2CCC(N3CCCCC3)CC2)c(Cl)c1)C1(c2ccccc2)CCC1";"Ki";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL437863";"";"None";"4267.74";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"2.13";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL2440912";"";"None";"1832.07";"None";"None";"(S,S)-49, UR-MEK381";"NCCN(CCNC(=O)CCC(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1)CCNC(=O)CCC(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"3.47";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL19299";"LOXOPROFEN";"4.0";"246.31";"0";"2.79";"LOXOPROFEN";"CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL553025";"VINORELBINE";"4.0";"778.95";"2";"4.75";"VINORELBINE";"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909078";"SODIUM ARSENITE";"None";"129.91";"None";"None";"SODIUM ARSENITE";"O=[As][O-].[Na+]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL972";"SELEGILINE";"4.0";"187.29";"0";"2.18";"SELEGILINE";"C#CCN(C)[C@H](C)Cc1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL75435";"DEXKETOPROFEN";"4.0";"254.29";"0";"3.11";"DEXKETOPROFEN";"C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201356";"METHYLERGONOVINE";"4.0";"339.44";"0";"1.92";"METHYLERGONOVINE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL648";"CYCLIZINE";"4.0";"266.39";"0";"3.02";"CYCLIZINE";"CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL27";"PROPRANOLOL";"4.0";"259.35";"0";"2.58";"PROPRANOLOL";"CC(C)NCC(O)COc1cccc2ccccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1113";"AMOXAPINE";"4.0";"313.79";"0";"3.43";"AMOXAPINE";"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200600";"FLUOROMETHOLONE";"4.0";"376.47";"0";"2.92";"FLUOROMETHOLONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1630578";"TIRILAZAD";"3.0";"624.87";"2";"5.46";"TIRILAZAD";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL822";"TERBINAFINE";"4.0";"291.44";"0";"4.88";"TERBINAFINE";"CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL551311";"";"None";"476.02";"1";"5.53";"24";"Cc1cccc(C(C)(C)C(=O)Nc2ccc(N3CCN(C(=O)c4ccccc4)CC3)c(Cl)c2)c1";"Ki";"'='";"5.012";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2440935";"";"None";"785.87";"2";"2.70";"(R)-29";"NCCCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440925";"";"None";"1655.93";"None";"None";"(R,R)-45";"NCCN(CCNC(=O)CCC(=O)NCCCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1)CCNC(=O)CCC(=O)NCCCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"Ki";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"3.82";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL311469";"2-ACETYLAMINOFLUORENE";"None";"223.27";"0";"3.22";"2-ACETYLAMINOFLUORENE";"CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL262777";"VANCOMYCIN";"4.0";"1449.27";"None";"None";"VANCOMYCIN";"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL446";"SULFAMETHAZINE";"4.0";"278.34";"0";"1.48";"SULFAMETHAZINE";"Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1766";"DESOXIMETASONE";"4.0";"376.47";"0";"2.78";"DESOXIMETASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1087";"MEPIVACAINE";"4.0";"246.35";"0";"2.73";"MEPIVACAINE";"Cc1cccc(C)c1NC(=O)C1CCCCN1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349039";"";"None";"4267.74";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"2.11";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL479";"THIORIDAZINE";"4.0";"370.59";"1";"5.89";"THIORIDAZINE";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1237044";"TRAMADOL";"4.0";"263.38";"0";"2.63";"TRAMADOL";"COc1cccc(C2(O)CCCCC2CN(C)C)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL13209";"NITRAZEPAM";"4.0";"281.27";"0";"2.38";"NITRAZEPAM";"O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440908";"";"None";"960.02";"2";"0.19";"(R)-81";"NCCOCCOCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440921";"";"None";"701.75";"2";"2.46";"(R)-44";"NCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1430";"PENICILLAMINE";"4.0";"149.21";"0";"0.11";"PENICILLAMINE";"CC(C)(S)[C@@H](N)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1065";"METHYSERGIDE";"None";"353.47";"0";"1.94";"METHYSERGIDE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL331202";"";"None";"494.04";"1";"5.07";"14";"Cn1c(COc2ccc(Cl)cc2)c(C(=O)C(=O)N2CCC(N3CCCCC3)CC2)c2ccccc21";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL441204";"";"None";"2539.13";"None";"None";"5";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"988.0";"nM";"6.00";"";"";"UO_0000065";"2.37";"None";"None";"None";"0";"CHEMBL747207";"Compound was tested for the displacement of [125I]-PYY(3-36) (SK-N-BE2) from Neuropeptide Y receptor type 2 in the membranes prepared from cells";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129485";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1071";"OXAPROZIN";"4.0";"293.32";"0";"4.03";"OXAPROZIN";"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1521";"ZALEPLON";"4.0";"305.34";"0";"2.64";"zaleplon";"CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL413426";"";"None";"2420.90";"None";"None";"4";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CSSC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OC";"Ki";"'='";"1120.0";"nM";"5.95";"";"";"UO_0000065";"2.46";"None";"None";"None";"0";"CHEMBL752930";"Affinity for cloned Y2 receptor using [125I]PYY as radioligand";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134468";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL1527608";"DOXOFYLLINE";"3.0";"266.26";"0";"-1.19";"DOXOFYLLINE";"Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL578";"ENALAPRIL";"4.0";"376.45";"0";"1.60";"ENALAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL84158";"TIAPRIDE";"3.0";"328.43";"0";"1.17";"TIAPRIDE";"CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL637";"VENLAFAXINE";"4.0";"277.41";"0";"3.04";"VENLAFAXINE";"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"DANAZOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL560117";"";"None";"429.95";"0";"4.30";"10";"COc1ccccc1C(=O)N1CCN(c2ccc(NC(=O)C(C)(C)C)cc2Cl)CC1";"Ki";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL564159";"";"None";"429.95";"0";"4.30";"11";"COc1cccc(C(=O)N2CCN(c3ccc(NC(=O)C(C)(C)C)cc3Cl)CC2)c1";"Ki";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL549565";"";"None";"433.94";"0";"4.48";"21";"O=C(Cc1ccccc1)Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1";"Ki";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL549976";"";"None";"461.99";"1";"5.22";"32";"CC(C)(C(=O)Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)cc1Cl)c1ccccc1";"Ki";"'='";"3162.28";"nM";"5.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2371911";"";"None";"1724.06";"None";"None";"4B";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"3.72";"None";"None";"None";"0";"CHEMBL870718";"Displacement of [125I]NPY from human NPY2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146122";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1288048";"";"None";"440.03";"1";"5.71";"14";"CC(C)(C(=O)Nc1ccc(N2CCC(N3CCCCC3)CC2)c(Cl)c1)c1ccccc1";"Ki";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1237";"LISINOPRIL ANHYDROUS";"4.0";"405.50";"0";"1.24";"LISINOPRIL";"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL757";"NANDROLONE";"3.0";"274.40";"0";"3.49";"NANDROLONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200545";"DIFLORASONE DIACETATE";"4.0";"494.53";"0";"2.99";"DIFLORASONE DIACETATE";"CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL428647";"PACLITAXEL";"4.0";"853.92";"2";"3.74";"Taxol";"CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1371937";"PANTHENOL";"3.0";"205.25";"0";"-1.14";"PANTHENOL";"CC(C)(CO)C(O)C(=O)NCCCO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL560716";"";"None";"467.92";"1";"5.31";"14";"CC(C)(C)C(=O)Nc1ccc(N2CCN(C(=O)c3ccc(C(F)(F)F)cc3)CC2)c(Cl)c1";"Ki";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL561719";"";"None";"445.54";"0";"4.70";"29";"CC(C)(C(=O)Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(F)c1)c1ccccc1";"Ki";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL550559";"";"None";"529.99";"2";"6.24";"33";"CC(C)(C(=O)Nc1ccc(N2CCN(C(=O)c3ccccc3C(F)(F)F)CC2)c(Cl)c1)c1ccccc1";"Ki";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1200629";"VECURONIUM BROMIDE";"4.0";"637.74";"2";"5.97";"VECURONIUM BROMIDE";"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1554";"DACTINOMYCIN";"4.0";"1255.44";"None";"None";"DACTINOMYCIN";"Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL452";"CLONAZEPAM";"4.0";"315.72";"0";"3.04";"CLONAZEPAM";"O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL334255";"CETYLPYRIDINIUM BROMIDE";"None";"384.45";"1";"6.46";"CETYLPYRIDINIUM BROMIDE";"CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL49";"BUSPIRONE";"4.0";"385.51";"0";"2.09";"BUSPIRONE";"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200559";"LACTIC ACID";"4.0";"90.08";"0";"-0.55";"LACTIC ACID";"CC(O)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1042";"CHOLECALCIFEROL";"4.0";"384.65";"1";"7.62";"SID17388665";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL504760";"CAMPHOR";"4.0";"152.24";"0";"2.40";"D-CAMPHOR";"CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL549";"CITALOPRAM";"4.0";"324.40";"0";"3.81";"CITALOPRAM";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL521";"IBUPROFEN";"4.0";"206.28";"0";"3.07";"SID138460";"CC(C)Cc1ccc(C(C)C(=O)O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3746870";"";"None";"616.72";"2";"2.67";"7";"CCOC(=O)CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3750366";"Displacement of Cy5-pNPY from human NPY2R expressed in CHO cells by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";"";"";""
"CHEMBL608";"PROBUCOL";"4.0";"516.86";"2";"9.91";"PROBUCOL";"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL856";"PRIMIDONE";"4.0";"218.26";"0";"0.54";"PRIMIDONE";"CCC1(c2ccccc2)C(=O)NCNC1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440185";"";"None";"1673.95";"None";"None";"8";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1506.0";"nM";"5.82";"";"";"UO_0000065";"3.48";"None";"None";"None";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440198";"";"None";"748.89";"2";"-3.18";"20";"CC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL549895";"";"None";"467.92";"1";"5.31";"13";"CC(C)(C)C(=O)Nc1ccc(N2CCN(C(=O)c3cccc(C(F)(F)F)c3)CC2)c(Cl)c1";"Ki";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL563650";"";"None";"413.95";"0";"4.68";"16";"CCC(C)(C)C(=O)Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1";"Ki";"'='";"50.12";"nM";"7.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL561577";"";"None";"427.93";"0";"3.81";"(+/-)-19";"O=C(Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1)C1CCCCO1";"Ki";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2440933";"";"None";"817.87";"2";"1.17";"(S)-25";"NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL511460";"";"None";"544.66";"2";"2.74";"5";"CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3750366";"Displacement of Cy5-pNPY from human NPY2R expressed in CHO cells by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";"";"";""
"CHEMBL411979";"";"None";"3340.85";"None";"None";"19";"CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H]1CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]2CCCN2C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N)Cc2ccc(O)cc2)C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O";"Ki";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"2.57";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL2370633";"";"None";"2199.51";"None";"None";"7";"CC[C@H](C)[C@H](NC(=O)[C@@H]1CNC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"4.33";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL88";"CYCLOPHOSPHAMIDE ANHYDROUS";"4.0";"261.09";"0";"1.88";"CYCLOPHOSPHAMIDE";"O=P1(N(CCCl)CCCl)NCCCO1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL460291";"LACIDIPINE";"4.0";"455.55";"0";"4.40";"LACIDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440191";"";"None";"1681.98";"None";"None";"14";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440920";"";"None";"827.91";"2";"2.10";"(R)-42";"CCC(=O)NCC(=O)NCCCCNC(=O)NCc1ccc(CNC(=O)[C@@H](CCCNC(=N)N)NC(=O)C(c2ccccc2)c2ccccc2)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440910";"";"None";"1018.10";"2";"0.59";"(R)-82";"NCCCOCCOCCOCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440906";"";"None";"1085.16";"2";"-1.33";"(R)-80";"NCCC(=O)NCCNC(=O)CCC(=O)NCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440904";"";"None";"1014.08";"2";"-0.83";"(R)-79";"NCCNC(=O)CCC(=O)NCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440897";"";"None";"1018.10";"2";"0.59";"(S)-82";"NCCCOCCOCCOCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440190";"";"None";"1667.00";"None";"None";"13";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H]1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)CC";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440911";"";"None";"1832.07";"None";"None";"(R,R)-49, UR-MK177";"NCCN(CCNC(=O)CCC(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1)CCNC(=O)CCC(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"3.14";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440928";"";"None";"1747.98";"None";"None";"(R,R)-48";"NCCN(CCNC(=O)CCCC(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1)CCNC(=O)CCCC(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"Ki";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"3.56";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL188921";"BUFLOMEDIL";"4.0";"307.39";"0";"2.77";"BUFLOMEDIL";"COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL174";"AMPICILLIN";"4.0";"349.41";"0";"0.32";"AMPICILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL42710";"EUGENOL";"0.5";"164.20";"0";"2.13";"EUGENOL";"C=CCc1ccc(O)c(OC)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL469912";"PUROMYCIN";"2.0";"471.52";"1";"-0.79";"PUROMYCIN";"COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"VERAPAMIL";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440922";"";"None";"1152.29";"None";"None";"(S)-56";"NCCCCCCNC(=O)/N=C(/N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O.O=C(O)C(F)(F)F";"Ki";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"7.85";"None";"None";"None";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL534";"KETOTIFEN";"4.0";"309.43";"0";"4.01";"KETOTIFEN";"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2311081";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"2.15";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL514";"LOMUSTINE";"4.0";"233.70";"0";"2.25";"LOMUSTINE";"O=NN(CCCl)C(=O)NC1CCCCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL275742";"DEXPROPRANOLOL";"-1.0";"259.35";"0";"2.58";"SID11113604";"CC(C)NC[C@@H](O)COc1cccc2ccccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL439122";"";"None";"2221.60";"None";"None";"3";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"4.05";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL437656";"";"None";"3340.85";"None";"None";"17";"CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]2CCCN2C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N)Cc2ccc(O)cc2)C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O";"Ki";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"2.66";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL159";"VINBLASTINE";"4.0";"810.99";"2";"3.99";"Vinblastine";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL471";"SOTALOL";"4.0";"272.37";"0";"1.09";"SOTALOL";"CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1288015";"";"None";"403.93";"0";"4.79";"6, amine";"CC(C)(C)C(=O)Nc1ccc(N2CCN(Cc3ccc(F)cc3)CC2)c(Cl)c1";"Ki";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL422";"TRIFLUOPERAZINE";"4.0";"407.51";"0";"4.95";"TRIFLUOPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL43064";"CINNARIZINE";"4.0";"368.52";"1";"5.11";"CINNARIZINE";"C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL571";"KETOPROFEN";"4.0";"254.29";"0";"3.11";"KETOPROFEN";"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL942";"BISACODYL";"4.0";"361.40";"0";"4.11";"BISACODYL";"CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1196";"PROPARACAINE";"4.0";"294.39";"0";"2.56";"PROPARACAINE";"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL13";"METOPROLOL";"4.0";"267.37";"0";"1.61";"METOPROLOL";"COCCc1ccc(OCC(O)CNC(C)C)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1230813";"ALFADEX";"2.0";"972.85";"3";"-13.05";"ALPHA-CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL6437";"MIANSERIN";"4.0";"264.37";"0";"3.08";"MIANSERIN";"CN1CCN2c3ccccc3Cc3ccccc3C2C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL438548";"";"None";"1760.14";"None";"None";"8";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CSSC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747207";"Compound was tested for the displacement of [125I]-PYY(3-36) (SK-N-BE2) from Neuropeptide Y receptor type 2 in the membranes prepared from cells";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129485";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL3559671";"POLYVINYL ALCOHOL";"4.0";"None";"None";"None";"POLYVINYL ALCOHOL";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL222863";"OUABAIN";"4.0";"584.66";"3";"-1.51";"OUABAIN";"C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL45";"MELATONIN";"4.0";"232.28";"0";"1.86";"MELATONIN";"COc1ccc2[nH]cc(CCNC(C)=O)c2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL7002";"CIGLITAZONE";"2.0";"333.45";"0";"3.93";"CIGLITAZONE";"CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL826";"ENOXACIN";"4.0";"320.32";"0";"0.66";"ENOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909067";"";"None";"None";"None";"None";"MC 258714";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL429071";"";"None";"2368.91";"None";"None";"3";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"3980.0";"nM";"5.40";"";"";"UO_0000065";"2.28";"None";"None";"None";"0";"CHEMBL747207";"Compound was tested for the displacement of [125I]-PYY(3-36) (SK-N-BE2) from Neuropeptide Y receptor type 2 in the membranes prepared from cells";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129485";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL15245";"YOHIMBINE";"4.0";"354.45";"0";"2.65";"YOHIMBINE";"COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL559662";"";"None";"427.93";"0";"3.67";"20";"O=C(Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1)C1CCOCC1";"Ki";"'>'";"6309.57";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL160";"CYCLOSPORINE";"4.0";"1202.63";"None";"None";"CYCLOSPORIN A";"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1073";"GLIPIZIDE";"4.0";"445.55";"0";"2.08";"GLIPIZIDE";"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL445206";"ISOEUGENOL";"None";"164.20";"0";"2.43";"ISOEUGENOL";"C/C=C\c1ccc(O)c(OC)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1287953";"";"None";"536.04";"2";"5.77";"2";"CC(C)(C(=O)Nc1ccc(N2CCC3(CCN(CC4CC4)C3)CC2)c(Cl)c1)c1nccc(C(F)(F)F)n1";"Ki";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1288108";"";"None";"399.97";"0";"4.83";"19";"CCNC1CCN(c2ccc(NC(=O)C(C)(C)c3ccccc3)cc2Cl)CC1";"Ki";"'='";"1995.26";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1288199";"";"None";"440.03";"1";"5.53";"24";"Cc1cccc(C(C)(C)C(=O)Nc2ccc(N3CCC(NCC4CC4)CC3)c(Cl)c2)c1";"Ki";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL306043";"GOLD SODIUM THIOMALATE";"4.0";"346.11";"None";"None";"GOLD SODIUM THIOMALATE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"2.14";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL659";"GALANTAMINE";"4.0";"287.36";"0";"1.85";"GALANTAMINE";"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL36715";"PIRACETAM";"4.0";"142.16";"0";"-0.91";"PIRACETAM";"NC(=O)CN1CCCC1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL773";"GLYCINE";"4.0";"75.07";"0";"-0.97";"GLYCINE";"NCC(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1433";"DOXYCYCLINE ANHYDROUS";"4.0";"444.44";"1";"-0.35";"Doxycycline, DOX";"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL701";"BACLOFEN";"4.0";"213.66";"0";"1.86";"BACLOFEN";"NCC(CC(=O)O)c1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1366";"AURANOFIN";"4.0";"678.49";"None";"None";"AURANOFIN";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL227456";"";"None";"1737.01";"None";"None";"1";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"4.0";"nM";"8.40";"";"Antagonist";"UO_0000065";"4.83";"None";"None";"None";"1";"CHEMBL914220";"Displacement of [125I]PYY from human NPY2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147158";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"ANTAGONIST";""
"CHEMBL404";"TAZOBACTAM";"4.0";"300.30";"0";"-1.52";"TAZOBACTAM";"C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL127";"MEROPENEM";"4.0";"383.47";"0";"-0.31";"meropenem";"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL398440";"CHLOROXYLENOL";"4.0";"156.61";"0";"2.66";"CHLOROXYLENOL";"Cc1cc(O)cc(C)c1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL56337";"EPALRESTAT";"4.0";"319.41";"0";"2.92";"EPALRESTAT";"CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL451";"CHLORDIAZEPOXIDE";"4.0";"299.76";"0";"2.95";"CHLORDIAZEPOXIDE";"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL19019";"NALTREXONE";"4.0";"341.41";"0";"1.53";"NALTREXONE";"O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201203";"BENZTROPINE";"4.0";"307.44";"0";"4.42";"BENZTROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL547";"ISOTRETINOIN";"4.0";"300.44";"1";"5.60";"ISOTRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL550583";"";"None";"492.02";"1";"5.23";"34";"COc1ccccc1C(=O)N1CCN(c2ccc(NC(=O)C(C)(C)c3ccccc3)cc2Cl)CC1";"Ki";"'='";"2.512";"nM";"8.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL270299";"BAY-11-7085";"None";"249.34";"0";"2.80";"BAY-117085";"CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL50588";"EMETINE";"2.0";"480.65";"0";"4.94";"EMETINE";"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1464";"WARFARIN";"4.0";"308.33";"0";"3.61";"WARFARIN";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL28079";"ZAPRINAST";"2.0";"271.28";"0";"1.50";"ZAPRINAST";"CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200845";"HALCINONIDE";"4.0";"454.97";"0";"3.89";"HALCINONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1730";"CEFOTAXIME";"4.0";"455.47";"1";"-0.62";"Cefotaxime";"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1419";"SIBUTRAMINE";"4.0";"279.86";"0";"4.74";"SIBUTRAMINE";"CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909051";"";"None";"347.38";"0";"4.80";"4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE";"O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1109";"SULFAPHENAZOLE";"4.0";"314.37";"0";"2.26";"SULFAPHENAZOLE";"Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1219";"RABEPRAZOLE";"4.0";"359.45";"0";"2.99";"RABEPRAZOLE";"COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL404520";"CHLORTETRACYCLINE";"4.0";"478.89";"1";"0.44";"CHLORTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL141343";"";"None";"520.72";"1";"4.21";"U-78517F";"Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1287814";"";"None";"489.06";"1";"5.96";"(+/-)-18";"O=C(Nc1ccc(N2CCC(N3CCCCC3)CC2)c(Cl)c1)C(c1ccccc1)c1ccccn1";"Ki";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL539730";"";"None";"399.92";"0";"4.29";"3, amide";"CC(C)(C)C(=O)Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)c(Cl)c1";"Ki";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1287899";"";"None";"417.91";"0";"4.43";"6, amide";"CC(C)(C)C(=O)Nc1ccc(N2CCN(C(=O)c3ccc(F)cc3)CC2)c(Cl)c1";"Ki";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1288078";"";"None";"508.03";"2";"6.73";"17";"CC(C)(C(=O)Nc1ccc(N2CCC(N3CCCCC3)CC2)c(Cl)c1)c1cccc(C(F)(F)F)c1";"Ki";"'='";"15.85";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1055";"CHLORTHALIDONE";"4.0";"338.77";"0";"0.92";"CHLORTHALIDONE";"NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL57";"NEVIRAPINE";"4.0";"266.30";"0";"2.65";"NVP";"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1177";"PEMOLINE";"4.0";"176.18";"0";"0.60";"PEMOLINE";"NC1=NC(=O)C(c2ccccc2)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL983";"SUCCINYLCHOLINE CHLORIDE";"4.0";"361.31";"0";"0.27";"SUXAMETHONIUM CHLORIDE";"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL374478";"RIFAMPIN";"4.0";"822.95";"3";"4.34";"rifampicin";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200748";"CARBIDOPA";"4.0";"244.25";"0";"-0.05";"S(-)-CARBIDOPA";"C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL12131";"CLOSANTEL";"2.0";"663.08";"2";"7.12";"CLOSANTEL";"Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL902";"FAMOTIDINE";"4.0";"337.46";"0";"-0.77";"FAMOTIDINE";"NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL276832";"HYDRALAZINE";"4.0";"160.18";"0";"0.92";"HYDRALAZINE";"NNc1nncc2ccccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL917";"FLOXURIDINE";"4.0";"246.19";"0";"-1.68";"5-FdU";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1130";"DOXIFLURIDINE";"3.0";"246.19";"0";"-1.69";"DOXIFLURIDINE";"C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL414804";"OXALIPLATIN";"4.0";"395.27";"None";"None";"OXALIPLATIN";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL803";"CYTARABINE";"4.0";"243.22";"0";"-2.56";"CYTARABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL364713";"NOSCAPINE";"4.0";"413.43";"0";"2.88";"NOSCAPINE";"COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL897";"PROBENECID";"4.0";"285.37";"0";"2.20";"PROBENECID";"CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL918";"PHENACEMIDE";"4.0";"178.19";"0";"0.42";"PHENACEMIDE";"NC(=O)NC(=O)Cc1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL508102";"CARBIMAZOLE";"4.0";"186.24";"0";"1.56";"CARBIMAZOLE";"CCOC(=O)n1ccn(C)c1=S";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL182";"GANCICLOVIR";"4.0";"255.23";"0";"-1.97";"GANCICLOVIR";"Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL723";"CARVEDILOL";"4.0";"406.48";"0";"3.74";"CARVEDILOL";"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2079587";"STANOZOLOL";"4.0";"328.50";"0";"4.12";"STANOZOLOL";"C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1444";"LETROZOLE";"4.0";"285.31";"0";"2.66";"LETROZOLE";"N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL686";"MEFENAMIC ACID";"4.0";"241.29";"0";"3.75";"MEFENAMIC ACID";"Cc1cccc(Nc2ccccc2C(=O)O)c1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1515";"METHIMAZOLE";"4.0";"114.17";"0";"0.71";"METHIMAZOLE";"Cn1ccnc1S";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL49080";"CLENBUTEROL";"4.0";"277.19";"0";"3.00";"CLENBUTEROL";"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL280998";"CATECHOL";"None";"110.11";"0";"1.10";"CATECHOL";"Oc1ccccc1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4287140";"";"None";"4019.50";"None";"None";"30";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"1.44";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4288294";"";"None";"4064.54";"None";"None";"3";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"6.31";"nM";"8.20";"";"";"UO_0000065";"2.02";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4280392";"";"None";"4064.54";"None";"None";"4";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1.259";"nM";"8.90";"";"";"UO_0000065";"2.19";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4291016";"";"None";"4064.54";"None";"None";"8";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N(C)[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"1.53";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1201353";"DEXCHLORPHENIRAMINE";"4.0";"274.80";"0";"3.82";"DEXCHLORPHENIRAMINE";"CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4293564";"";"None";"4064.54";"None";"None";"7";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N(C)[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"1.40";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4291016";"";"None";"4064.54";"None";"None";"8";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N(C)[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"1.53";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1475";"TRIOXSALEN";"4.0";"228.25";"0";"3.46";"TRIOXSALEN";"Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL727";"THIOGUANINE";"4.0";"167.20";"0";"0.60";"THIOGUANINE";"Nc1nc2[nH]cnc2c(=S)[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201207";"BETAMETHASONE PHOSPHORIC ACID";"4.0";"472.45";"0";"2.01";"BETAMETHASONE PHOSPHATE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL563568";"";"None";"467.92";"1";"5.31";"12";"CC(C)(C)C(=O)Nc1ccc(N2CCN(C(=O)c3ccccc3C(F)(F)F)CC2)c(Cl)c1";"Ki";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1062219";"Antagonist activity at human neuropeptide Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL421";"SULFASALAZINE";"4.0";"398.40";"0";"3.70";"SULFASALAZINE";"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1727";"CEPHALEXIN ANHYDROUS";"4.0";"347.40";"0";"0.44";"CEPHALEXIN";"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL286398";"PROPYLENE GLYCOL";"3.0";"76.10";"0";"-0.64";"PROPYLENE GLYCOL";"CC(O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1540";"PENCICLOVIR";"4.0";"253.26";"0";"-0.90";"PENCICLOVIR";"Nc1nc(O)c2ncn(CCC(CO)CO)c2n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL828";"PHENOTHIAZINE";"2.0";"199.28";"0";"3.89";"PHENOTHIAZINE";"c1ccc2c(c1)Nc1ccccc1S2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL926";"DOBUTAMINE";"4.0";"301.39";"0";"2.96";"DOBUTAMINE";"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL185";"FLUOROURACIL";"4.0";"130.08";"0";"-0.80";"5-FU";"O=c1[nH]cc(F)c(=O)[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4642752";"";"None";"803.97";"2";"-3.30";"21";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL1282";"IMIQUIMOD";"4.0";"240.31";"0";"2.82";"IMIQUIMOD";"CC(C)Cn1cnc2c(N)nc3ccccc3c21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL101168";"";"None";"134.14";"0";"0.15";"1-AMINOBENZOTRIAZOLE";"Nn1nnc2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL809";"SERTRALINE";"4.0";"306.24";"1";"5.18";"SERTRALINE";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL572";"NITROFURANTOIN";"4.0";"238.16";"0";"0.07";"NITROFURANTOIN";"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1753";"CLINDAMYCIN";"4.0";"424.99";"0";"0.39";"Clindamycin";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL107";"COLCHICINE";"4.0";"399.44";"0";"2.87";"colchicine";"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL114";"SAQUINAVIR";"4.0";"670.86";"1";"3.09";"SAQUINAVIR";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL29";"BENZYLPENICILLIN";"4.0";"334.40";"0";"0.86";"PENICILLIN G";"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1388";"MONOBENZONE";"4.0";"200.24";"0";"2.97";"MONOBENZONE";"Oc1ccc(OCc2ccccc2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL621";"TRAZODONE";"4.0";"371.87";"0";"2.36";"TRAZODONE";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201117";"METHOCARBAMOL";"4.0";"241.24";"0";"0.53";"METHOCARBAMOL";"COc1ccccc1OCC(O)COC(N)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"2.08";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL47";"ALPHA-TOCOPHEROL";"None";"430.72";"1";"8.84";"ALPHA-TOCOPHEROL";"Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"FLUOXETINE";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1568";"FLUDARABINE";"None";"285.24";"0";"-1.84";"F-AraA";"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL34431";"CILOSTAMIDE";"2.0";"342.44";"0";"3.48";"CILOSTAMIDE";"CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201346";"BALSALAZIDE";"4.0";"357.32";"0";"2.71";"BALSALAZIDE";"O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1370";"BUDESONIDE";"4.0";"430.54";"0";"2.72";"BUDESONIDE";"CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1287984";"";"None";"403.93";"0";"4.79";"4, amine";"CC(C)(C)C(=O)Nc1ccc(N2CCN(Cc3ccccc3F)CC2)c(Cl)c1";"Ki";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1774211";"";"None";"1031.19";"3";"6.30";"54";"Cc1cc(/C=C/c2cc3c4c(c2)CCCN4CCC3)cc(C)[n+]1CCNC(=O)CCCC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C([O-])C(F)(F)F";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1777149";"Displacement of Dy-635-pNPY from human Y2R expressed in CHO cells by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1773009";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL852";"MELPHALAN";"4.0";"305.21";"0";"1.93";"MELPHALAN";"N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL459";"METHYLDOPA";"4.0";"211.22";"0";"0.44";"METHYLDOPA";"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL92401";"IPRONIAZID";"4.0";"179.22";"0";"0.72";"IPRONIAZID";"CC(C)NNC(=O)c1ccncc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3545252";"DOCETAXEL";"4.0";"861.94";"2";"3.26";"2";"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1221";"SULCONAZOLE";"4.0";"397.76";"1";"6.52";"SULCONAZOLE";"Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1726";"NISOLDIPINE";"4.0";"388.42";"0";"3.20";"NISOLDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL35";"FUROSEMIDE";"4.0";"330.75";"0";"1.89";"1";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4290445";"";"None";"4137.59";"None";"None";"28";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.63";"nM";"9.20";"";"";"UO_0000065";"2.22";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL439122";"";"None";"2221.60";"None";"None";"35";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"3.56";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4277697";"";"None";"4064.54";"None";"None";"18";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"39.81";"nM";"7.40";"";"";"UO_0000065";"1.82";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4280898";"";"None";"4050.51";"None";"None";"24";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(CC(=O)O)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C";"Ki";"'='";"1258.93";"nM";"5.90";"";"";"UO_0000065";"1.46";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL267345";"AMPHOTERICIN B";"4.0";"924.09";"3";"0.71";"AnfB";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL569";"PROCAINE";"4.0";"236.31";"0";"1.77";"PROCAINE";"CCN(CC)CCOC(=O)c1ccc(N)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL63323";"NIFLUMIC ACID";"2.0";"282.22";"0";"3.54";"NIFLUMIC ACID";"O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL56367";"NIMESULIDE";"4.0";"308.31";"0";"2.76";"NIMESULIDE";"CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1489";"AZACITIDINE";"4.0";"244.21";"0";"-3.17";"AZACITIDINE";"Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL695";"TRIMETHADIONE";"4.0";"143.14";"0";"0.37";"TRIMETHADIONE";"CN1C(=O)OC(C)(C)C1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1231";"OXYBUTYNIN";"4.0";"357.49";"0";"3.34";"OXYBUTYNIN";"CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL98350";"LY-294002";"-1.0";"307.35";"0";"3.30";"LY-294002";"O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201631";"INSULIN HUMAN";"4.0";"None";"None";"None";"INSULIN";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL14053";"TRICHLOROACETIC ACID";"4.0";"163.39";"0";"1.44";"TRICHLOROACETIC ACID";"O=C(O)C(Cl)(Cl)Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1670";"MITOTANE";"4.0";"320.05";"1";"5.93";"MITOTANE";"Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL632";"BETAMETHASONE";"4.0";"392.47";"0";"1.90";"BETAMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL768";"ESMOLOL";"4.0";"295.38";"0";"1.53";"ESMOLOL";"COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL990";"BUTENAFINE";"4.0";"317.48";"1";"5.77";"BUTENAFINE";"CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL37858";"SARAFLOXACIN";"-1.0";"385.37";"0";"2.38";"SARAFLOXACIN";"O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL844";"BRIMONIDINE";"4.0";"292.14";"0";"1.76";"BRIMONIDINE";"Brc1c(NC2=NCCN2)ccc2nccnc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL221886";"SISOMICIN";"3.0";"447.53";"2";"-3.85";"SISOMICIN";"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL588119";"SULOCTIDIL";"None";"337.57";"1";"5.56";"SULOCTIDIL";"CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1386";"TRANSPLATIN";"3.0";"300.05";"None";"None";"TRANS-PLATINUM(II)DIAMMINE DICHLORIDE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200693";"MANGANESE CHLORIDE ANHYDROUS";"4.0";"125.84";"None";"None";"MANGANESE (II) CHLORIDE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1172";"DESLORATADINE";"4.0";"310.83";"0";"4.02";"DESLORATADINE";"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1902627";"CLORPRENALINE";"-1.0";"213.71";"0";"2.37";"CLORPRENALINE";"CC(C)NCC(O)c1ccccc1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1544";"LIOTHYRONINE";"4.0";"650.98";"1";"3.95";"3,3',5-TRIIODO-L-THYRONINE";"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2107687";"VALETHAMATE BROMIDE";"-1.0";"386.37";"0";"3.85";"VALETHAMATE BROMIDE";"CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL34259";"METHOTREXATE";"4.0";"454.45";"0";"0.27";"METHOTREXATE";"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4873376";"";"None";"1121.32";"None";"None";"18";"CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCCNC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4860290";"";"None";"1125.30";"None";"None";"27";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4857577";"";"None";"1107.29";"None";"None";"28";"CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCNC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4874445";"";"None";"1180.34";"None";"None";"30";"N=C(N)NCCC[C@@H]1NC(=O)CCC(=O)NCCCNC(=O)NC(=N)NCCC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4873376";"";"None";"1121.32";"None";"None";"18";"CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCCNC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4868787";"";"None";"1125.30";"None";"None";"31";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)NC(=O)NCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4861544";"";"None";"1107.29";"None";"None";"32";"CC(C)C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)NCCCNC(=O)NC(=N)NCCC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC1=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL3104111";"";"None";"2644.30";"None";"None";"198, NPY-BBB2";"CCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(=O)NCCCCCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC";"Ki";"'='";"26.1";"nM";"7.58";"";"";"UO_0000065";"2.87";"None";"None";"None";"0";"CHEMBL3106329";"Binding affinity to NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL679";"EPINEPHRINE";"4.0";"183.21";"0";"0.35";"EPINEPHRINE";"CNC[C@H](O)c1ccc(O)c(O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3350037";"";"None";"1019.26";"None";"None";"OCTREOTIDE";"C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1454";"LEVAMISOLE";"4.0";"204.30";"0";"2.15";"LEVAMISOLE";"c1ccc([C@H]2CN3CCSC3=N2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL136478";"SODIUM NITROPRUSSIDE";"4.0";"261.92";"None";"None";"SODIUM NITROPRUSSIDE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1288139";"";"None";"413.99";"1";"5.22";"21";"CCCNC1CCN(c2ccc(NC(=O)C(C)(C)c3ccccc3)cc2Cl)CC1";"Ki";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1288226";"";"None";"426.99";"0";"4.62";"26";"CC(C)(C(=O)Nc1ccc(N2CCC(NCC3CC3)CC2)c(Cl)c1)c1ccccn1";"Ki";"'='";"1258.93";"nM";"5.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1630579";"MYRTECAINE";"2.0";"265.44";"0";"3.73";"MYRTECAINE";"CCN(CC)CCOCCC1=CCC2CC1C2(C)C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1741";"CLARITHROMYCIN";"4.0";"747.96";"2";"2.44";"CLARITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL5315124";"LEVOFLOXACIN";"4.0";"740.76";"0";"1.54";"LEVOFLOXACIN";"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL456807";"PHENYLHYDRAZINE";"None";"108.14";"0";"0.97";"PHENYLHYDRAZINE";"NNc1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1489254";"TRIACETIN";"2.0";"218.21";"0";"0.04";"TRIACETIN";"CC(=O)OCC(COC(C)=O)OC(C)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL283196";"ALPHA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"ALPHA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL666";"FOSCARNET";"4.0";"126.00";"0";"-0.16";"FOSCARNET";"O=C(O)P(=O)(O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL267633";"NEUROPEPTIDE-Y";"None";"4253.71";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.081";"nM";"10.09";"";"";"UO_0000065";"2.37";"None";"None";"None";"0";"CHEMBL947366";"Displacement of radiolabeled NPY from human neuropeptide Y2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140203";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL1200406";"DIMENHYDRINATE";"4.0";"469.97";"None";"None";"DIMENHYDRINATE";"CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2370625";"";"None";"2213.54";"None";"None";"8";"CC[C@H](C)[C@H](NC(=O)[C@@H]1CNC(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"4.30";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL331937";"";"None";"591.24";"2";"6.79";"R(18)";"O=C(CN1CCC(N2CCCCC2)CC1)c1c(COc2ccc(Cl)cc2)n(CCC[C@H]2CCCNC2)c2ccccc12";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL427974";"";"None";"2241.59";"None";"None";"10";"CC[C@@H](C)[C@@H](NC(=O)[C@@H]1CCCCNC(=O)C[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](Cc2c[nH]cn2)C(=O)N1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)O)[C@H](C)O)[C@H](C)CC";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"4.15";"None";"None";"None";"0";"CHEMBL750764";"Tested against neuropeptide Y2 receptors using SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126588";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL56564";"TROPISETRON";"4.0";"284.36";"0";"2.95";"Tropisetron ICS-205-930";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1c[nH]c3ccccc13)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL42442";"OXFENDAZOLE";"2.0";"315.35";"0";"2.91";"OXFENDAZOLE";"COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21";"SULFANILAMIDE";"4.0";"172.21";"0";"-0.08";"SULFANILAMIDE";"Nc1ccc(S(N)(=O)=O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL329536";"";"None";"591.24";"2";"6.79";"S(18)";"O=C(CN1CCC(N2CCCCC2)CC1)c1c(COc2ccc(Cl)cc2)n(CCC[C@@H]2CCCNC2)c2ccccc12";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL410780";"";"None";"2685.24";"None";"None";"6";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"621.0";"nM";"6.21";"";"";"UO_0000065";"2.31";"None";"None";"None";"0";"CHEMBL747207";"Compound was tested for the displacement of [125I]-PYY(3-36) (SK-N-BE2) from Neuropeptide Y receptor type 2 in the membranes prepared from cells";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129485";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL289469";"GRANISETRON";"4.0";"312.42";"0";"2.32";"GRANISETRON";"CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1566249";"AMPIROXICAM";"2.0";"447.47";"0";"2.56";"AMPIROXICAM";"CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL493";"BROMOCRIPTINE";"4.0";"654.61";"1";"3.19";"Bromocriptine";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL413965";"FELBINAC";"4.0";"212.25";"0";"2.98";"FELBINAC";"O=C(O)Cc1ccc(-c2ccccc2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL583";"GREPAFLOXACIN";"4.0";"359.40";"0";"2.28";"GREPAFLOXACIN";"Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL389621";"HYDROCORTISONE";"4.0";"362.47";"0";"1.78";"HYDROCORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4277676";"";"None";"4064.54";"None";"None";"16";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.79";"nM";"9.10";"";"";"UO_0000065";"2.24";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL393255";"";"None";"1890.26";"None";"None";"PYY(24-36)-L31-C37";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(N)=O)[C@@H](C)O";"Ki";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"3.54";"None";"None";"None";"0";"CHEMBL897470";"Displacement of [125I]PYY from human NPY2 receptor in KAN-TS cells by SPA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148865";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL153479";"AMBROXOL";"3.0";"378.11";"0";"3.19";"AMBROXOL";"Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909049";"";"None";"309.41";"0";"3.79";"1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL562";"GRISEOFULVIN";"4.0";"352.77";"0";"2.81";"G";"COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL577294";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"3.0";"1541.55";"None";"None";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"CC(O)COC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8COCC(C)O)O[C@@H]7COCC(C)O)O[C@@H]6COCC(C)O)O[C@@H]5COCC(C)O)O[C@@H]4COCC(C)O)O[C@@H]3COCC(C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2110196";"";"None";"2685.24";"None";"None";"7";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"704.0";"nM";"6.15";"";"";"UO_0000065";"2.29";"None";"None";"None";"0";"CHEMBL747207";"Compound was tested for the displacement of [125I]-PYY(3-36) (SK-N-BE2) from Neuropeptide Y receptor type 2 in the membranes prepared from cells";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129485";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL392889";"";"None";"1659.92";"None";"None";"5";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"Ki";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"4.53";"None";"None";"None";"0";"CHEMBL902327";"Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL2220442";"FLUVASTATIN";"4.0";"411.47";"0";"4.63";"FLUVASTATIN";"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL472";"GLYBURIDE";"4.0";"494.01";"0";"3.64";"SID11113353";"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL481";"IRINOTECAN";"4.0";"586.69";"1";"4.09";"IRINOTECAN";"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1542";"AZATHIOPRINE";"4.0";"277.27";"0";"1.15";"AZATHIOPRINE";"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440186";"";"None";"1658.98";"None";"None";"9";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL4866086";"";"None";"958.14";"3";"-3.29";"20";"CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCCNC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4870168";"";"None";"1162.37";"None";"None";"23";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL640";"PROCAINAMIDE";"4.0";"235.33";"0";"1.34";"PROCAINAMIDE";"CCN(CC)CCNC(=O)c1ccc(N)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL165790";"IPRIFLAVONE";"2.0";"280.32";"0";"4.25";"IPRIFLAVONE";"CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL940";"GABAPENTIN";"4.0";"171.24";"0";"1.37";"GABAPENTIN";"NCC1(CC(=O)O)CCCCC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL614";"PYRAZINAMIDE";"4.0";"123.11";"0";"-0.42";"PYRAZINAMIDE";"NC(=O)c1cnccn1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL531";"PERGOLIDE";"4.0";"314.50";"0";"4.27";"21";"CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL7568";"QUINACRINE";"2.0";"399.97";"1";"5.97";"QUINACRINE";"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL184618";"FRAMYCETIN";"3.0";"614.65";"3";"-8.90";"NEOMYCIN";"NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL487894";"DIPYRONE SODIUM";"None";"333.35";"0";"0.77";"DIPYRONE";"Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909048";"";"None";"313.83";"0";"4.43";"1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1381098";"1-NAPHTHYLISOTHIOCYANATE";"None";"185.25";"0";"3.57";"1-NAPHTHYL ISOTHIOCYANATE";"S=C=Nc1cccc2ccccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL415";"CLOMIPRAMINE";"4.0";"314.86";"0";"4.53";"CLOMIPRAMINE";"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL154111";"SALSALATE";"4.0";"258.23";"0";"2.31";"SALSALATE";"O=C(Oc1ccccc1C(=O)O)c1ccccc1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL245416";"L-MIMOSINE";"None";"198.18";"0";"-1.03";"L-MIMOSINE";"N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL877";"TRANEXAMIC ACID";"4.0";"157.21";"0";"0.84";"TRANEXAMIC ACID";"NC[C@H]1CC[C@H](C(=O)O)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL976";"PRAZIQUANTEL";"4.0";"312.41";"0";"2.53";"PRAZIQUANTEL";"O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909063";"LEAD(IV) ACETATE";"None";"443.38";"None";"None";"LEAD(IV) ACETATE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL923";"RISEDRONIC ACID";"4.0";"283.11";"0";"-0.37";"RISEDRONIC ACID";"O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3746386";"";"None";"843.78";"2";"2.25";"38; UR-MK299";"CCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3750366";"Displacement of Cy5-pNPY from human NPY2R expressed in CHO cells by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";"";"";""
"CHEMBL744";"RILUZOLE";"4.0";"234.20";"0";"2.78";"RILUZOLE";"Nc1nc2ccc(OC(F)(F)F)cc2s1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1148";"TORSEMIDE";"4.0";"348.43";"0";"2.53";"TORSEMIDE";"Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1288256";"";"None";"442.01";"0";"4.32";"28";"Cc1ccnc(C(C)(C)C(=O)Nc2ccc(N3CCC(NCC4CC4)CC3)c(Cl)c2)n1";"Ki";"'='";"794.33";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1291628";"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287792";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2440188";"";"None";"1642.94";"None";"None";"11";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"1a";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"2.13";"None";"None";"None";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL580";"LORAZEPAM";"4.0";"321.16";"0";"3.10";"LORAZEPAM";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL563";"FLURBIPROFEN";"4.0";"244.26";"0";"3.68";"FLURBIPROFEN";"CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1480";"FELODIPINE";"4.0";"384.26";"0";"3.96";"FELODIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1477";"CERIVASTATIN";"4.0";"459.56";"0";"4.88";"CERIVASTATIN";"COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4281010";"";"None";"2250.60";"None";"None";"37";"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)[C@@H](C)O)[C@@H](C)CC)NC(=O)[C@H](CC(N)=O)NC1=O";"Ki";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"3.87";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1351";"CARBOPLATIN";"4.0";"371.25";"None";"None";"CARBOPLATIN";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1117";"IDARUBICIN";"4.0";"497.50";"0";"1.02";"IDARUBICIN";"CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1614641";"FLUNOXAPROFEN";"2.0";"285.27";"0";"3.82";"FLUNOXAPROFEN";"C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1481";"GLIMEPIRIDE";"4.0";"490.63";"0";"3.07";"GLIMEPIRIDE";"CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL134";"CLONIDINE";"4.0";"230.10";"0";"2.36";"CLONIDINE";"Clc1cccc(Cl)c1NC1=NCCN1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1425";"MERCAPTOPURINE ANHYDROUS";"4.0";"152.18";"0";"0.64";"6-MERCAPTOPURINE";"Sc1ncnc2nc[nH]c12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL24441";"BETAHISTINE";"4.0";"136.20";"0";"0.84";"BETAHISTINE";"CNCCc1ccccn1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1108";"DROPERIDOL";"4.0";"379.44";"0";"3.68";"DROPERIDOL";"O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201010";"FLUDROCORTISONE ACETATE";"4.0";"422.49";"0";"2.44";"FLUDROCORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1873703";"DIELDRIN";"2.0";"380.91";"0";"4.48";"DIELDRIN";"ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@@H]([C@H]5O[C@@H]45)[C@@H]3[C@@]1(Cl)C2(Cl)Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL435";"HYDROCHLOROTHIAZIDE";"4.0";"297.75";"0";"-0.35";"HYDROCHLOROTHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL290916";"EDARAVONE";"4.0";"174.20";"0";"1.80";"EDARAVONE";"CC1=NN(c2ccccc2)C(=O)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909071";"";"None";"None";"None";"None";"NOVARTIS P-38 INHIBITOR";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL402794";"BIS(2-ETHYLHEXYL)PHTHALATE";"None";"390.56";"1";"6.43";"BIS(2-ETHYLHEXYL)PHTHALATE";"CCCC[C@@H](CC)COC(=O)c1ccccc1C(=O)OC[C@@H](CC)CCCC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL31184";"BENZO[DEF]CHRYSENE";"0.5";"252.32";"1";"5.74";"BENZO[A]PYRENE";"c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL121799";"";"None";"382.94";"1";"5.44";"11";"Cn1c(COc2ccc(Cl)cc2)c(CCN2CCCCC2)c2ccccc21";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747206";"Affinity for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130228";"1";"Scientific Literature";"J Med Chem";"1997";"None";"";"";""
"CHEMBL221753";"BENZETHONIUM CHLORIDE";"2.0";"448.09";"1";"6.07";"BENZETHONIUM CHLORIDE";"CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL850";"SPARFLOXACIN";"4.0";"392.41";"0";"2.08";"SPARFLOXACIN";"C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1762";"TOCAINIDE";"4.0";"192.26";"0";"1.59";"TOCAINIDE";"Cc1cccc(C)c1NC(=O)C(C)N";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL447";"SECOBARBITAL";"4.0";"238.29";"0";"1.35";"SECOBARBITAL";"C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL195437";"4-OCTYLPHENOL";"None";"206.33";"0";"4.30";"4-OCTYLPHENOL";"CCCCCCCCc1ccc(O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL13378";"(R,S)-AMPA";"None";"186.17";"0";"-0.36";"(RS)-AMPA";"Cc1onc(O)c1CC(N)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL77675";"";"None";"211.27";"0";"3.15";"1,3-DIPHENYLGUANIDINE";"N=C(Nc1ccccc1)Nc1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL696";"ETHOSUXIMIDE";"4.0";"141.17";"0";"0.45";"ETHOSUXIMIDE";"CCC1(C)CC(=O)NC1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL25";"ASPIRIN";"4.0";"180.16";"0";"1.31";"ASPIRIN";"CC(=O)Oc1ccccc1C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL433257";"HARRINGTONINE";"None";"531.60";"1";"2.19";"HARRINGTONINE";"COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL384467";"DEXAMETHASONE";"4.0";"392.47";"0";"1.90";"DEXAMETHASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1503";"OMEPRAZOLE";"4.0";"345.42";"0";"2.90";"OMEPRAZOLE";"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200709";"CROTAMITON";"4.0";"203.28";"0";"2.92";"CROTAMITON";"C/C=C/C(=O)N(CC)c1ccccc1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909057";"COPPER(II) OXIDE";"None";"79.55";"None";"None";"COPPER(II) OXIDE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL468";"THALIDOMIDE";"4.0";"258.23";"0";"0.09";"THALIDOMIDE";"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200679";"ZINC CHLORIDE";"4.0";"136.30";"None";"None";"ZINC CHLORIDE";"[Cl-].[Cl-].[Zn+2]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4475071";"";"None";"1706.04";"None";"None";"(2S,7S)-2";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"950.0";"nM";"6.02";"";"";"UO_0000065";"3.53";"None";"None";"None";"0";"CHEMBL4478050";"Displacement of [3H]propionyl-pNPY from human NPY Y2 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477203";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4581302";"";"None";"1520.80";"None";"None";"21";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4478050";"Displacement of [3H]propionyl-pNPY from human NPY Y2 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477203";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL408891";"";"None";"1538.83";"None";"None";"5";"CCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"1050.0";"nM";"5.98";"";"";"UO_0000065";"3.89";"None";"None";"None";"0";"CHEMBL870718";"Displacement of [125I]NPY from human NPY2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146122";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";"";"";""
"CHEMBL2440119";"";"None";"746.87";"2";"-3.43";"21";"CC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440192";"";"None";"4153.77";"None";"None";"2";"CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](N)Cc1ccc(O)cc1";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440189";"";"None";"1670.99";"None";"None";"12";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1C[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)C1(C)C)[C@@H](C)O)[C@@H](C)CC";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440902";"";"None";"943.00";"2";"-0.34";"(R)-78";"NCCC(=O)NCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440919";"";"None";"771.84";"2";"1.54";"(R)-41";"N=C(N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(=O)NCCCCNC(=O)CN)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440934";"";"None";"729.80";"2";"3.24";"(R)-27";"NCCCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440932";"";"None";"817.87";"2";"1.17";"(R)-25";"NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL332347";"";"None";"473.58";"0";"2.38";"(R)-1a, BIBP3226";"NC(N)=NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440916";"";"None";"1872.08";"None";"None";"(R,R)-52";"CCC(=O)NCCN(CCNC(=O)c1ccc(C(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)cc1)CCNC(=O)c1ccc(C(=O)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)cc1.O=C(O)C(F)(F)F";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440930";"";"None";"761.80";"2";"1.71";"(R)-24";"NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2440903";"";"None";"943.00";"2";"-0.34";"(S)-78";"NCCC(=O)NCCNC(=O)CCC(=O)NCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1.O=C(O)C(F)(F)F";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2446800";"Binding affinity to human neuropeptide Y receptor type 2 receptor expressed in CHO cells using Cy5-pNPY by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439953";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL307145";"PYROGALLOL";"4.0";"126.11";"0";"0.80";"PYROGALLOL";"Oc1cccc(O)c1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2105807";"MADURAMICIN";"2.0";"934.17";"2";"4.32";"MADURAMICIN";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C.N";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL461727";"AMYGDALIN";"None";"457.43";"2";"-3.11";"AMYGDALIN(D)";"N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL516";"CYPROHEPTADINE";"4.0";"287.41";"0";"4.70";"CYPROHEPTADINE";"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL488";"AMINOGLUTETHIMIDE";"4.0";"232.28";"0";"1.35";"AMINOGLUTETHIMIDE";"CCC1(c2ccc(N)cc2)CCC(=O)NC1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4858915";"";"None";"1093.26";"None";"None";"16";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4540843";"PANCREATIC POLYPEPTIDE";"2.0";"4181.78";"None";"None";"hpp";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4848958";"";"None";"1093.30";"None";"None";"22";"CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCCNC(=O)CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4292105";"";"None";"4050.51";"None";"None";"PYY(3-36)";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"2.32";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL257940";"";"None";"393.48";"0";"3.64";"21c, trans";"CC(=O)N1CCC(N(C)C(=O)N[C@H]2CC[C@H](c3cc(F)cc(F)c3)CC2)CC1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL948252";"Binding affinity to human NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143109";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL4287058";"";"None";"4064.54";"None";"None";"10";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"2.12";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4286615";"";"None";"4241.83";"None";"None";"31";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O";"Ki";"'='";"5.012";"nM";"8.30";"";"";"UO_0000065";"1.96";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3746851";"";"None";"725.73";"2";"2.05";"33";"Cn1cc(CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)nn1.O=C(O)C(F)(F)F";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3750366";"Displacement of Cy5-pNPY from human NPY2R expressed in CHO cells by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4279794";"";"None";"4123.57";"None";"None";"27";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.2512";"nM";"9.60";"";"";"UO_0000065";"2.33";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4281010";"";"None";"2250.60";"None";"None";"37";"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)[C@@H](C)O)[C@@H](C)CC)NC(=O)[C@H](CC(N)=O)NC1=O";"Ki";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"3.87";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL20";"ACETAZOLAMIDE";"4.0";"222.25";"0";"-0.86";"AAZ";"CC(=O)Nc1nnc(S(N)(=O)=O)s1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL295416";"PIRINIXIC ACID";"2.0";"323.81";"0";"3.67";"PIRINIXIC ACID";"Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1754";"DOXAPRAM";"4.0";"378.52";"0";"3.17";"DOXAPRAM";"CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201469";"GRAMICIDIN";"4.0";"None";"None";"None";"GRAMICIDIN";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL115";"INDINAVIR";"4.0";"613.80";"1";"2.87";"INDINAVIR";"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL787";"MONTELUKAST";"4.0";"586.20";"2";"8.95";"MONTELUKAST";"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL157548";"DANOFLOXACIN";"-1.0";"357.39";"0";"2.07";"DANOFLOXACIN";"CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1198";"PRAMOXINE";"4.0";"293.41";"0";"2.97";"PRAMOXINE";"CCCCOc1ccc(OCCCN2CCOCC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200396";"BUPIVACAINE HYDROCHLORIDE";"4.0";"324.90";"0";"3.90";"BUPIVACAINE HYDROCHLORIDE";"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201024";"METHSCOPOLAMINE BROMIDE";"None";"398.30";"0";"1.06";"METHSCOPOLAMINE BROMIDE";"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@H]12.[Br-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL453";"SULFISOXAZOLE";"4.0";"267.31";"0";"1.67";"SULFISOXAZOLE";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1149";"LEVOCARNITINE";"4.0";"161.20";"0";"-1.81";"LEVOCARNITINE";"C[N+](C)(C)C[C@H](O)CC(=O)[O-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL437";"SULFATHIAZOLE";"4.0";"255.32";"0";"1.53";"SULFATHIAZOLE";"Nc1ccc(S(=O)(=O)Nc2nccs2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2106399";"KITASAMYCIN";"2.0";"785.97";"2";"2.44";"KITASAMYCIN";"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL81";"RALOXIFENE";"4.0";"473.59";"1";"6.08";"Raloxifene";"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3349022";"";"None";"4253.71";"None";"None";"table I";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"2.03";"None";"None";"None";"0";"CHEMBL824200";"Affinity against Neuropeptide Y2 receptor on SK-N-BE2 human neuroblastoma cells";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126946";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL4276961";"";"None";"4182.77";"None";"None";"PP(1-36)";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O";"Ki";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"1.27";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL84";"TOPOTECAN";"4.0";"421.45";"0";"1.85";"TPT";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL959";"RIMANTADINE";"4.0";"179.31";"0";"2.55";"RIMANTADINE";"CC(N)C12CC3CC(CC(C3)C1)C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL86304";"MOCLOBEMIDE";"4.0";"268.74";"0";"1.40";"MOCLOBEMIDE";"O=C(NCCN1CCOCC1)c1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL268291";"DIMETHYLFORMAMIDE";"None";"73.10";"0";"-0.30";"N,N-DIMETHYLFORMAMIDE";"CN(C)C=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1440";"TETRACYCLINE";"4.0";"444.44";"1";"-0.21";"TETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL325372";"METHYLPARABEN";"-1.0";"152.15";"0";"1.18";"METHYLPARABEN";"COC(=O)c1ccc(O)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL108545";"METHYL SALICYLATE";"4.0";"152.15";"0";"1.18";"METHYL SALICYLATE";"COC(=O)c1ccccc1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1447";"LINCOMYCIN";"4.0";"406.55";"0";"-0.86";"LINCOMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL416";"METHOXSALEN";"4.0";"216.19";"0";"2.55";"METHOXSALEN";"COc1c2occc2cc2ccc(=O)oc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1333512";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"None";"260.34";"1";"5.17";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1428";"NIMODIPINE";"4.0";"418.45";"0";"2.97";"NIMODIPINE";"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL313493";"METHANESULFONIC ACID METHYL ESTER";"None";"110.13";"0";"-0.41";"METHYL METHANESULFONATE";"COS(C)(=O)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL267648";"PEFLOXACIN";"4.0";"333.36";"0";"1.61";"PEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1502";"PANTOPRAZOLE";"4.0";"383.38";"0";"2.88";"PANTOPRAZOLE";"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL611";"TERAZOSIN";"4.0";"387.44";"0";"1.06";"TERAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL110691";"CHLORMADINONE ACETATE";"4.0";"404.93";"0";"4.75";"CHLORMADINONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL498847";"SECNIDAZOLE";"4.0";"185.18";"0";"0.48";"SECNIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CC(C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL122";"ROFECOXIB";"4.0";"314.36";"0";"2.56";"ROFECOXIB";"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL564201";"6-AZAURIDINE";"None";"245.19";"0";"-3.46";"AZAURIDINE";"O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL134342";"THIOCTIC ACID";"None";"206.33";"0";"2.79";"THIOCTIC ACID";"O=C(O)CCCC[C@@H]1CCSS1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1255901";"HUPERZINE A";"2.0";"242.32";"0";"2.00";"HUPERZINE A";"C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL894";"BUPROPION";"4.0";"239.75";"0";"3.30";"BUPROPION";"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL532";"ERYTHROMYCIN";"4.0";"733.94";"2";"1.79";"ERY";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL475534";"NITRENDIPINE";"4.0";"360.37";"0";"2.57";"NITRENDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"ASTEMIZOLE";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1399";"ANASTROZOLE";"4.0";"293.37";"0";"2.93";"ANASTROZOLE";"CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL820";"BUSULFAN";"4.0";"246.31";"0";"-0.28";"BUSULFAN";"CS(=O)(=O)OCCCCOS(C)(=O)=O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4646733";"";"None";"951.15";"3";"-2.57";"18";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4642345";"";"None";"619.77";"2";"-1.96";"35";"CN[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4633593";"";"None";"967.15";"3";"-2.87";"1; UR-KK236";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4633581";"";"None";"1040.20";"None";"None";"12";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4639709";"";"None";"605.75";"2";"-2.23";"29; UR-AK32";"CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4643497";"";"None";"605.75";"2";"-2.23";"33";"CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL1068";"OXCARBAZEPINE";"4.0";"252.27";"0";"2.64";"OXCARBAZEPINE";"NC(=O)N1c2ccccc2CC(=O)c2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1732";"DIHYDROERGOTAMINE";"4.0";"583.69";"1";"2.08";"DIHYDROERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL293492";"CINNAMALDEHYDE";"-1.0";"132.16";"0";"1.90";"CINNAMALDEHYDE";"O=C/C=C/c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200528";"CHROMIC CHLORIDE";"4.0";"158.36";"None";"None";"CHROMIUM(III) CHLORIDE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL557555";"CIPROFIBRATE";"4.0";"289.16";"0";"3.59";"CIPROFIBRATE";"CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL511";"PYRILAMINE";"4.0";"285.39";"0";"2.66";"PYRILAMINE";"COc1ccc(CN(CCN(C)C)c2ccccn2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1297";"FENOPROFEN";"4.0";"242.27";"0";"3.67";"FENOPROFEN";"CC(C(=O)O)c1cccc(Oc2ccccc2)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL657";"DIPHENHYDRAMINE";"4.0";"255.36";"0";"3.35";"DIPHENHYDRAMINE";"CN(C)CCOC(c1ccccc1)c1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909054";"CARBOXYMETHYLCELLULOSE";"None";"None";"None";"None";"CARBOXYMETHYLCELLULOSE";"";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4291705";"";"None";"4063.56";"None";"None";"1";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NC)[C@@H](C)O)C(C)C";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"1.48";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4291705";"";"None";"4063.56";"None";"None";"1";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NC)[C@@H](C)O)C(C)C";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"1.48";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4279973";"";"None";"4064.54";"None";"None";"5";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"2.19";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4279973";"";"None";"4064.54";"None";"None";"5";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1.259";"nM";"8.90";"";"";"UO_0000065";"2.19";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL181";"DIAZOXIDE";"4.0";"230.68";"0";"1.68";"DIAZOXIDE";"CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1902981";"EPERISONE";"3.0";"259.39";"0";"3.55";"EPERISONE";"CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL629";"AMITRIPTYLINE";"4.0";"277.41";"0";"4.17";"AMITRIPTYLINE";"CN(C)CCC=C1c2ccccc2CCc2ccccc21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL485549";"NIFURSOL";"2.0";"365.21";"0";"1.47";"NIFURSOL";"O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4289021";"";"None";"4036.49";"None";"None";"19";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"1.88";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4283257";"";"None";"4137.59";"None";"None";"29";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"2.10";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL565";"CLOFIBRATE";"4.0";"242.70";"0";"3.06";"CLOFIBRATE";"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL888";"GEMCITABINE";"4.0";"263.20";"0";"-1.29";"GEMCITABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL64894";"GENTIAN VIOLET";"4.0";"407.99";"0";"4.46";"GENTIAN VIOLET";"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL252557";"GLYCOLIC ACID";"2.0";"76.05";"0";"-0.94";"GLYCOLIC ACID";"O=C(O)CO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL467";"HYDROXYUREA";"4.0";"76.05";"0";"-0.96";"HYDROXYUREA";"NC(=O)NO";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200633";"IVERMECTIN";"4.0";"1736.18";"None";"None";"IVERMECTIN";"CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL417";"EPIRUBICIN";"4.0";"543.53";"3";"0.00";"EPIRUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL643";"PROMETHAZINE";"4.0";"284.43";"0";"4.24";"Promethazine";"CC(CN1c2ccccc2Sc2ccccc21)N(C)C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL55";"PENTAMIDINE";"4.0";"340.43";"0";"2.88";"3";"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL16068";"BROMOBENZENE";"None";"157.01";"0";"2.45";"BROMOBENZENE";"Brc1ccccc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL802";"MINOXIDIL";"4.0";"209.25";"0";"-0.13";"MINOXIDIL";"Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL603";"ZAFIRLUKAST";"4.0";"575.69";"2";"5.70";"ZAFIRLUKAST";"COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL434";"ISOPROTERENOL";"4.0";"211.26";"0";"1.13";"ISOPRENALINE";"CC(C)NCC(O)c1ccc(O)c(O)c1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4643458";"";"None";"1161.38";"None";"None";"24";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CCCN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4290445";"";"None";"4137.59";"None";"None";"28";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.631";"nM";"9.20";"";"";"UO_0000065";"2.22";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4278700";"";"None";"4213.78";"None";"None";"32";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O";"Ki";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"1.95";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4283705";"";"None";"4064.54";"None";"None";"12";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"1.62";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4290891";"";"None";"4064.54";"None";"None";"13";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"1.67";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1159650";"CLOBETASOL PROPIONATE";"4.0";"466.98";"0";"4.10";"CLOBETASOL PROPIONATE";"CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1513";"IRBESARTAN";"4.0";"428.54";"0";"4.78";"IRBESARTAN";"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL60889";"MOSAPRIDE";"3.0";"421.90";"0";"3.09";"MOSAPRIDE";"CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4641659";"";"None";"926.09";"3";"-2.86";"16";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4641831";"";"None";"791.96";"2";"-1.02";"22";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL540445";"PARTHENOLIDE";"2.0";"248.32";"0";"2.76";"PARTHENOLIDE";"C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21";"Ki";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4292105";"";"None";"4050.51";"None";"None";"PYY(3-36)";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.3981";"nM";"9.40";"";"";"UO_0000065";"2.32";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4633593";"";"None";"967.15";"3";"-2.87";"3 ;UR-KK236";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4877802";"";"None";"976.15";"3";"-3.38";"19";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4874850";"";"None";"1198.36";"None";"None";"29";"N=C(N)NCCC[C@H](NC(=O)CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)NC(=O)NCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4289416";"";"None";"4078.57";"None";"None";"22";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"1.67";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4283257";"";"None";"4137.59";"None";"None";"29";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"2.10";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4293564";"";"None";"4064.54";"None";"None";"7";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N(C)[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1995.26";"nM";"5.70";"";"";"UO_0000065";"1.40";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4281479";"";"None";"4310.81";"None";"None";"PYY(1-36)";"CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.2512";"nM";"9.60";"";"";"UO_0000065";"2.23";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4645738";"";"None";"926.09";"3";"-2.86";"14";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4646391";"";"None";"990.18";"3";"-2.09";"17";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4637617";"";"None";"1025.18";"None";"None";"20";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4641831";"";"None";"791.96";"2";"-1.02";"22";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4646391";"";"None";"990.18";"3";"-2.09";"17";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4633774";"";"None";"1047.24";"None";"None";"23";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4643341";"";"None";"1047.24";"None";"None";"27";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4282216";"";"None";"4034.47";"None";"None";"23";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CN(C(=N)N)C[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"7943.28";"nM";"5.10";"";"";"UO_0000065";"1.26";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4290488";"";"None";"4050.51";"None";"None";"25";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"1.48";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4276796";"";"None";"1699.94";"None";"None";"36";"CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC1=O";"Ki";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"4.18";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4287140";"";"None";"4019.50";"None";"None";"30";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1584.89";"nM";"5.80";"";"";"UO_0000065";"1.44";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3787712";"";"None";"1790.16";"None";"None";"17";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN/C(N)=N/C(=O)NCCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"3.43";"None";"None";"None";"0";"CHEMBL4478050";"Displacement of [3H]propionyl-pNPY from human NPY Y2 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477203";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4642345";"";"None";"619.77";"2";"-1.96";"35";"CN[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.076";"nM";"10.12";"";"";"UO_0000065";"2.37";"None";"None";"None";"0";"CHEMBL2394942";"Binding affinity to human neuropeptide Y receptor type 2 by radioligand displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390830";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL4576579";"";"None";"1505.79";"None";"None";"19";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4478050";"Displacement of [3H]propionyl-pNPY from human NPY Y2 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477203";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4287469";"";"None";"4064.54";"None";"None";"15";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C)CC(C)C";"Ki";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"1.80";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4852354";"";"None";"930.09";"3";"-4.93";"14";"CC(C)C[C@H](NC(=O)[C@@H]1CCC(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4865048";"";"None";"1139.33";"None";"None";"17";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4285633";"";"None";"4050.51";"None";"None";"17";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"2.512";"nM";"8.60";"";"";"UO_0000065";"2.12";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4289416";"";"None";"4078.57";"None";"None";"22";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"1.67";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL439122";"";"None";"2221.60";"None";"None";"35";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"3.55";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4294418";"";"None";"2262.66";"None";"None";"38";"CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)[C@@H](C)O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC1=O";"Ki";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"3.93";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4632871";"";"None";"998.16";"3";"-2.37";"13; UR-AK1";"N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4636233";"";"None";"1120.29";"None";"None";"26";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4637810";"";"None";"605.75";"2";"-2.23";"32";"CC(C)C[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4643154";"";"None";"605.75";"2";"-2.23";"34";"CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4284905";"";"None";"4272.74";"None";"None";"NPY(1-36)";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.79";"nM";"9.10";"";"";"UO_0000065";"2.13";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4284905";"";"None";"4272.74";"None";"None";"NPY(1-36)";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"Ki";"'='";"0.7943";"nM";"9.10";"";"";"UO_0000065";"2.13";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL2440200";"";"None";"808.94";"2";"-1.86";"23";"CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447454";"Displacement of Cy5-pNPY from human Y2 receptor expressed in CHO cells after 90 to 120 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308072";"";"";""
"CHEMBL4294277";"";"None";"4064.54";"None";"None";"11";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"2.12";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4278746";"";"None";"4064.54";"None";"None";"21";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"1.43";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4278746";"";"None";"4064.54";"None";"None";"21";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1584.89";"nM";"5.80";"";"";"UO_0000065";"1.43";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4290488";"";"None";"4050.51";"None";"None";"25";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"1.48";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4282616";"";"None";"4050.51";"None";"None";"26";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"2511.89";"nM";"5.60";"";"";"UO_0000065";"1.38";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4848958";"";"None";"1093.30";"None";"None";"22";"CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCCNC(=O)CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4866086";"";"None";"958.14";"3";"-3.29";"20";"CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCCNC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4862140";"";"None";"1111.32";"None";"None";"21";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4870168";"";"None";"1162.37";"None";"None";"23";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4278700";"";"None";"4213.78";"None";"None";"32";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O";"Ki";"'='";"6.31";"nM";"8.20";"";"";"UO_0000065";"1.95";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4287058";"";"None";"4064.54";"None";"None";"10";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"2.512";"nM";"8.60";"";"";"UO_0000065";"2.12";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4281479";"";"None";"4310.81";"None";"None";"PYY(1-36)";"CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.25";"nM";"9.60";"";"";"UO_0000065";"2.23";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4852354";"";"None";"930.09";"3";"-4.93";"14";"CC(C)C[C@H](NC(=O)[C@@H]1CCC(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4865048";"";"None";"1139.33";"None";"None";"17";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4863955";"";"None";"1212.38";"None";"None";"25";"N=C(N)NCCC[C@H](NC(=O)CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)NC(=O)NCCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4633593";"";"None";"967.15";"3";"-2.87";"3 ;UR-KK236";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4866955";"";"None";"916.06";"3";"-5.32";"15";"CC(C)C[C@H](NC(=O)[C@@H]1CC(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4852799";"";"None";"1194.37";"None";"None";"26";"N=C(N)NCCC[C@@H]1NC(=O)CCC(=O)NCCCCNC(=O)NC(=N)NCCC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4276796";"";"None";"1699.94";"None";"None";"36";"CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC1=O";"Ki";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"4.18";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4277697";"";"None";"4064.54";"None";"None";"18";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"1.82";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4286615";"";"None";"4241.83";"None";"None";"31";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O";"Ki";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"1.96";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4290048";"";"None";"4007.49";"None";"None";"33";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"1.62";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4294418";"";"None";"2262.66";"None";"None";"38";"CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)[C@@H](C)O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC1=O";"Ki";"'='";"1.259";"nM";"8.90";"";"";"UO_0000065";"3.93";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4277676";"";"None";"4064.54";"None";"None";"16";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.7943";"nM";"9.10";"";"";"UO_0000065";"2.24";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4649711";"";"None";"925.11";"3";"-3.04";"8";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4632871";"";"None";"998.16";"3";"-2.37";"13; UR-AK1";"N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4645738";"";"None";"926.09";"3";"-2.86";"14";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4643458";"";"None";"1161.38";"None";"None";"24";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CCCN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4280392";"";"None";"4064.54";"None";"None";"4";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"2.19";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4290615";"";"None";"4064.54";"None";"None";"6";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"1.65";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4279133";"";"None";"4064.54";"None";"None";"9";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CC(=O)O)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C";"Ki";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"1.75";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4649438";"";"None";"605.75";"2";"-2.23";"31";"CC(C)C[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4279794";"";"None";"4123.57";"None";"None";"27";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"Ki";"'='";"0.25";"nM";"9.60";"";"";"UO_0000065";"2.33";"None";"None";"None";"0";"CHEMBL4265254";"Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261636";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4522438";"";"None";"1762.10";"None";"None";"(2R,7R)-10";"CCC(=O)N[C@@H](CCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"3.62";"None";"None";"None";"0";"CHEMBL4478050";"Displacement of [3H]propionyl-pNPY from human NPY Y2 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477203";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4856311";"";"None";"1144.35";"None";"None";"24";"CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCCNC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4856311";"";"None";"1144.35";"None";"None";"24";"CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCCNC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4863955";"";"None";"1212.38";"None";"None";"25";"N=C(N)NCCC[C@H](NC(=O)CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)NC(=O)NCCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4857577";"";"None";"1107.29";"None";"None";"28";"CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCNC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4639709";"";"None";"605.75";"2";"-2.23";"29; UR-AK32";"CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4621609";"Displacement of [3H]propionyl-pNPY from human Y2 receptor expressed in CHO cells measured after 2 hrs by microbeta liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619778";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4540843";"PANCREATIC POLYPEPTIDE";"2.0";"4181.78";"None";"None";"hpp";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"Ki";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4862140";"";"None";"1111.32";"None";"None";"21";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4852799";"";"None";"1194.37";"None";"None";"26";"N=C(N)NCCC[C@@H]1NC(=O)CCC(=O)NCCCCNC(=O)NC(=N)NCCC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL4860290";"";"None";"1125.30";"None";"None";"27";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4841971";"Displacement of [3H]UR-MK299 from human neuropeptide Y Y2 receptor expressed in CHO cells measured after 90 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840359";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";""
